,pdb_id,chain_id,location,dssp_location,gene,amino_acid_original,list_amino_acid_variants,variants,description,antigen_name,antigen_chain,antigen_species
0,4JPV,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120,hiv-1 clade a strain 93th057 gp120 with loop d and loopd v5replaced from hiv strain 3415v1 ,G,human immunodeficiency virus 1
1,4OGX,L,50,50,IGKV1-5,K,['D' 'K'],D,Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.4 Angstrom resolution,plasma kallikrein,A,homo sapiens
2,4IDJ,H,54,54,IGHV1-69,L,['F' 'L'],F,S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus
3,4IDJ,H,56,56,IGHV1-69,T,['T' 'I'],I,S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus
4,4IDJ,H,73,73,IGHV1-69,K,['E' 'K'],E,S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus
5,2B1A,L,50,50,IGLV1-47,R,['R' 'S'],S,Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG1033 peptide,ug1033 peptide of exterior membrane glycoprotein gp120,P,
6,1TJI,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 17mer epitope,envelope glycoprotein gp41,P,
7,1TJH,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope,envelope glycoprotein gp41,P,
8,1TJG,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 7mer epitope,envelope glycoprotein gp41,P,
9,4TSB,H,54,54,IGHV3-66,G,['G' 'C'],C,Structure of a lysozyme antibody complex,lysozyme c,A,gallus gallus
10,7RXI,L,50,50,IGLV3-21,D,['Y' 'D'],Y,Fab234 in complex with the C-terminal alpha-TSR domain of P. falciparum,circumsporozoite protein,A,plasmodium falciparum (isolate 3d7)
11,6CMI,D,54,55,IGHV1-69,L,['F' 'L'],F,Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,B,hendra virus
12,6CMI,D,56,57,IGHV1-69,I,['T' 'I'],T,Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,B,hendra virus
13,6CMG,C,54,55,IGHV1-69,L,['F' 'L'],F,Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,A,hendra virus
14,6CMG,C,56,57,IGHV1-69,I,['T' 'I'],T,Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,A,hendra virus
15,6OZ3,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
16,1H0D,B,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens
17,1H0D,B,52A,52A,IGHV3-23,S,['G' 'S'],G,Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens
18,1H0D,B,53,53,IGHV3-23,G,['S' 'G'],S,Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens
19,7XNF,H,54,54,IGHV3-66,G,['G' 'C'],C,Structure of SARS-CoV-2 antibody P2C-1F11 with GX/P2V/2017 RBD,spike protein s1,A,pangolin coronavirus
20,6W52,H,54,54,IGHV1-69,F,['F' 'L'],L,Prefusion RSV F bound by neutralizing antibody RSB1,fusion glycoprotein f1 fused with fibritin trimerizationdomain  | fusion glycoprotein f0,B | A,"human respiratory syncytial virus a,escherichia phage t2  | human respiratory syncytial virus a (straina2) "
21,4TSA,H,54,54,IGHV3-66,G,['G' 'C'],C,Structure of a lysozyme FAb complex,lysozyme c,A,gallus gallus
22,4TSC,H,54,54,IGHV3-66,G,['G' 'C'],C,Structure of a lysozyme antibody complex,lysozyme c,A,gallus gallus
23,7E5O,H,50,50,IGHV4-34,E,['E' 'Y'],Y,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
24,7E5O,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],Y,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
25,7E5O,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],I,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
26,7E5O,H,59,59,IGHV4-34,Y,['Y' 'N'],N,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
27,7E5O,L,32,33,IGKV1-17,Y,['D' 'Y'],D,Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
28,7WP2,H,94,98,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 
29,7WP0,H,94,98,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 
30,7WP1,H,94,98,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 
31,5CD5,C,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of an immature VRC01-class antibody DRVIA7 from a Chinese donor bound to clade A/E HIV-1 gp120 core,93th057 hiv-1 gp120 core,A,human immunodeficiency virus 1
32,6OZ4,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain.,envelope glycoprotein gp160,G,human immunodeficiency virus 1
33,7TLZ,B,26,26,IGHV3-30,G,['G' 'A'],A,SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement,spike glycoprotein,J,homo sapiens
34,7TLZ,B,52,52,IGHV3-30,R,['S' 'R'],S,SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement,spike glycoprotein,J,homo sapiens
35,7SU1,H,50,50,IGHV3-30,F,['V' 'F'],V,Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4,cytotoxic t-lymphocyte protein 4,C,homo sapiens
36,7SU1,H,52,52,IGHV3-30,S,['S' 'R'],R,Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4,cytotoxic t-lymphocyte protein 4,C,homo sapiens
37,3GO1,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,
38,3GO1,H,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,
39,3GO1,H,58,58,IGHV4-59,N,['N' 'Y'],Y,Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,
40,7KRA,I,25,27,IGHV4-34,Y,['Y' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
41,7KRA,I,26,28,IGHV4-34,G,['G' 'F'],F,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
42,7KRA,I,27,29,IGHV4-34,G,['G' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
43,7KRA,I,28,30,IGHV4-34,S,['S' 'T' 'G'],T,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
44,7KRA,I,28,30,IGHV4-34,S,['S' 'T' 'G'],G,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
45,7KRA,I,29,31,IGHV4-34,F,['F' 'V' 'Y'],V,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
46,7KRA,I,29,31,IGHV4-34,F,['F' 'V' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
47,7KRA,I,30,32,IGHV4-34,S,['S' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
48,7KRA,I,31,33,IGHV4-34,G,['G' 'W'],W,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
49,7KRA,I,32,34,IGHV4-34,Y,['Y' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
50,7KRA,I,52,54,IGHV4-34,N,['N' 'Y' 'I'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
51,7KRA,I,52,54,IGHV4-34,N,['N' 'Y' 'I'],I,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
52,7KRA,I,53,55,IGHV4-34,H,['H' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae
53,7KET,A,52,52,IGHV3-23,S,['S' 'Y'],Y,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
54,7KET,A,53,54,IGHV3-23,S,['S' 'G'],G,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
55,7KET,A,55,56,IGHV3-23,G,['G' 'S'],S,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
56,7WRJ,A,54,56,IGHV2-5,D,['N' 'D'],N,Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-4637 Fab,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
57,7E3B,B,31,31,IGHV4-59,S,['S' 'Y'],Y,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
58,7E3B,B,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
59,7E3B,B,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
60,7E3B,B,33,33,IGHV4-59,Y,['Y' 'S'],S,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
61,7E3B,B,50,50,IGHV4-59,Y,['Y' 'R'],R,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
62,7E3B,B,53,53,IGHV4-59,Y,['Y' 'T'],T,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
63,7E3B,B,58,58,IGHV4-59,N,['N' 'Y'],Y,SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
64,7E39,C,31,31,IGHV3-33,S,['S' 'R'],R,SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
65,7E39,C,35,35,IGHV3-33,H,['H' 'Y'],Y,SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
66,7E39,C,52,52,IGHV3-33,W,['W' 'S'],S,SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
67,8DLX,H,26,26,IGHV3-30,G,['G' 'A'],A,Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
68,8DLX,H,94,97,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
69,8DLR,H,54,74,IGHV1-69,L,['F' 'L'],F,Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
70,7EKB,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1
71,7EKB,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1
72,7EKB,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1
73,7EKB,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1
74,7EKK,H,33,33,IGHV1-69,A,['A' 'T'],T,Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1
75,7EKK,H,50,50,IGHV1-69,G,['G' 'R'],R,Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1
76,7EKK,H,54,54,IGHV1-69,L,['F' 'L'],F,Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1
77,7EKK,H,56,56,IGHV1-69,I,['T' 'I'],T,Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1
78,7BYR,L,50,50,IGKV1-5,K,['D' 'K'],D,BD23-Fab in complex with the S ectodomain trimer,sars-cov-2 spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
79,7N8I,H,33,33,IGHV3-30,G,['A' 'G'],A,SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
80,7N8I,H,52,52,IGHV3-30,R,['S' 'R'],S,SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
81,6PWU,H,26,26,IGHV3-30,G,['G' 'A'],A,"Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab",envelope glycoprotein gp160 | envelope glycoprotein gp160 | envelope glycoprotein gp160,A | C | E,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
82,7SBU,H,50,50,IGHV1-69,R,['G' 'R'],G,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
83,7SBU,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
84,4NHC,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,
85,4NHC,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,
86,4NHC,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,
87,7AHV,B,50,50,IGKV1-5,K,['D' 'K'],D,Anti-FIXa Fab of mim8 in complex with human FIXa,coagulation factor ix,H,homo sapiens
88,6C5V,L,50,49,IGLV3-21,Y,['Y' 'D'],D,An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus,envelope glycoprotein h | glycoprotein 42 | envelope glycoprotein l,A | C | B,human herpesvirus 4 | human herpesvirus 4 | human herpesvirus 4
89,6D2P,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens
90,6D2P,H,61,62,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens
91,4RFO,H,33,33,IGHV4-31,G,['G' 'S'],S,Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1
92,4RFO,L,29,29,IGLV2-14,G,['G' 'S'],S,Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1
93,4RFO,L,32,32,IGLV2-14,Y,['Y' 'L'],L,Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1
94,6WO4,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1
95,6WO4,H,56,56,IGHV1-69,T,['T' 'I'],I,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1
96,6WO3,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1
97,6WO3,H,73,73,IGHV1-69,E,['E' 'K'],K,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1
98,6NMV,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens
99,6NMV,H,53,54,IGHV3-23,S,['S' 'G'],G,Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens
100,5TE4,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade G Strain X2088 gp120 Core,hiv-1 clade g strain x2088 gp120,G,human immunodeficiency virus 1
101,6UYN,H,54,55,IGHV1-69,F,['F' 'L'],L,Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab,hemagglutinin ha1 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus
102,6UYN,H,56,57,IGHV1-69,T,['T' 'I'],I,Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab,hemagglutinin ha1 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus
103,5TE7,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade C Strain DU172.17 gp120 Core,hiv-1 gp120 core,G,human immunodeficiency virus 1
104,6BLH,H,52,52,IGHV3-33,W,['W' 'S'],S,RSV G central conserved region bound to Fab CB017.5,major surface glycoprotein g,G,human respiratory syncytial virus a (strainrsb6256) 
105,6BLH,H,94,94,IGHV3-33,R,['R' 'K'],K,RSV G central conserved region bound to Fab CB017.5,major surface glycoprotein g,G,human respiratory syncytial virus a (strainrsb6256) 
106,5T85,H,50,50,IGHV3-15,R,['R' 'C'],C,Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidylglycerol (06:0 PG),10e8 epitope scaffold t117v2,G,synthetic construct
107,5T80,H,50,50,IGHV3-15,R,['R' 'C'],C,Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct
108,5T80,H,58,58,IGHV3-15,D,['D' 'N'],N,Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct
109,7BEH,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 
110,7EOW,B,52,53,IGHV3-23,S,['S' 'Y'],Y,"High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine",von willebrand factor,A,homo sapiens
111,2UZI,H,33,33,IGHV3-48,S,['S' 'E'],E,Crystal structure of HRAS(G12V) - anti-RAS Fv complex,gtpase hras,R,homo sapiens
112,6U36,L,69,69,IGKV3-11,T,['T' 'R'],R,PCSK9 in complex with a Fab and compound 14,proprotein convertase subtilisin/kexin type 9,B,homo sapiens
113,4XVJ,H,50,50,IGHV3-23,A,['A' 'V'],V,STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus
114,4XVJ,H,52,52,IGHV3-23,S,['S' 'Y'],Y,STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus
115,4XVJ,H,52A,53,IGHV3-23,S,['G' 'S'],G,STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus
116,4XVJ,H,53,54,IGHV3-23,S,['S' 'G'],G,STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus
117,4XVJ,L,50,51,IGLV1-51,D,['D' 'E'],E,STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus
118,4XVS,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),donor 45 01dg5 coree gp120,G,human immunodeficiency virus 1
119,4XVS,H,61,62,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),donor 45 01dg5 coree gp120,G,human immunodeficiency virus 1
120,4XVT,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),envelope glycoprotein gp120 of hiv-1 clade a/e,G,human immunodeficiency virus 1
121,4XVT,H,61,62,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),envelope glycoprotein gp120 of hiv-1 clade a/e,G,human immunodeficiency virus 1
122,7RAL,H,50,50,IGHV1-69,R,['G' 'R'],G,SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
123,7RAL,H,73,74,IGHV1-69,K,['E' 'K'],E,SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
124,5GMQ,B,33,30,IGHV1-69,A,['A' 'T'],T,Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus
125,5GMQ,B,50,47,IGHV1-69,R,['G' 'R'],G,Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus
126,5GMQ,B,54,52,IGHV1-69,L,['F' 'L'],F,Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus
127,5GMQ,B,73,71,IGHV1-69,K,['E' 'K'],E,Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus
128,6O2C,A,33,33,IGHV3-49,A,['A' 'P'],P,Crystal structure of 4493 Fab in complex with circumsporozoite protein NANP3 and anti-kappa VHH domain,circumsporozoite protein,C,plasmodium falciparum
129,6O26,A,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of 3246 Fab in complex with circumsporozoite protein NANA,circumsporozoite protein,C,plasmodium falciparum
130,6O24,A,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of 4498 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain,circumsporozoite protein,I,plasmodium falciparum
131,5F45,H,33,33,IGHV3-48,E,['S' 'E'],S,Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9),hemagglutinin ha1 chain,A,influenza a virus
132,6CO3,H,52,52,IGHV3-33,W,['W' 'S'],S,aducanumab abeta complex,ala-glu-phe-arg-his-asp,Q,homo sapiens
133,6UCF,H,50,50,IGHV1-2,W,['R' 'W'],R,N123-VRC34_pI4 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519,hiv fusion peptide,A,human immunodeficiency virus 1
134,5VL7,H,52,52,IGHV3-23,S,['S' 'Y'],Y,PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens
135,5VL7,L,30,30,IGKV1-13,S,['I' 'S'],I,PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens
136,5VL7,L,32,32,IGKV1-13,A,['S' 'A'],S,PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens
137,5MEV,H,50,50,IGHV3-21,S,['S' 'Y'],Y,MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21,"induced myeloid leukemia cell differentiation protein mcl-1homolog,induced myeloid leukemia cell differentiation protein mcl-1 ",A,"mus musculus, homo sapiens"
138,5MES,H,50,50,IGHV3-21,S,['S' 'Y'],Y,MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29,"induced myeloid leukemia cell differentiation protein mcl-1homolog,induced myeloid leukemia cell differentiation protein mcl-1 ",A,"mus musculus, homo sapiens"
139,4M5Z,L,50,50,IGLV3-21,D,['Y' 'D'],Y,"Crystal structure of broadly neutralizing antibody 5J8 bound to 2009 pandemic influenza hemagglutinin, HA1 subunit",hemagglutinin ha1 chain,A,influenza a virus
140,4HS8,H,58,58,IGHV3-11,N,['Y' 'N'],Y,Hepatitus C envelope glycoprotein E2 fragment 412-423 with humanized and affinity-matured antibody hu5B3.v3,e2-peptide,A,hepatitis c virus
141,7U9P,H,31,31,IGHV3-33,S,['S' 'R'],R,SARS-CoV-2 spike trimer RBD in complex with Fab NA8,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
142,7U9P,H,52,52,IGHV3-33,W,['W' 'S'],S,SARS-CoV-2 spike trimer RBD in complex with Fab NA8,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
143,7U9O,H,50,50,IGHV1-2,W,['R' 'W'],R,SARS-CoV-2 spike trimer RBD in complex with Fab NE12,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
144,7DUO,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens
145,7DUO,H,52A,53,IGHV3-23,G,['G' 'S'],S,Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens
146,7DUO,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens
147,7DUO,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens
148,4H8W,H,53,53,IGHV3-23,S,['S' 'G'],G,Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4.,hiv-1 clade a/e 93th057 (h375s) gp120,G,homo sapiens
149,7E9B,H,58,59,IGHV3-11,Y,['Y' 'N'],N,"Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy",programmed cell death protein 1,C,homo sapiens
150,4HPY,L,50,50,IGLV3-10,E,['E' 'K'],K,Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide,envelope glycoprotein gp160,P,human immunodeficiency virus 1
151,2PW2,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWKSL,peptide epitope,C,
152,2PW1,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWNSL,peptide epitope,C,
153,6VLN,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of 4498 Fab in complex with circumsporozoite protein DND3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library
154,5FGC,E,50,50,IGHV3-23,A,['A' 'V'],V,Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h)
155,5FGC,E,52,52,IGHV3-23,S,['S' 'Y'],Y,Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h)
156,5FGC,E,52A,53,IGHV3-23,S,['G' 'S'],G,Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h)
157,7S5P,L,50,50,IGLV3-21,D,['Y' 'D'],Y,Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
158,5C6T,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab,envelope glycoprotein b,A,human cytomegalovirus
159,5C6T,L,50,51,IGLV1-47,R,['R' 'S'],S,Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab,envelope glycoprotein b,A,human cytomegalovirus
160,2CMR,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
161,2CMR,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
162,2CMR,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
163,2CMR,H,56,56,IGHV1-69,T,['T' 'I'],I,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
164,2CMR,H,73,73,IGHV1-69,E,['E' 'K'],K,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
165,2CMR,L,50,50,IGKV1-5,K,['D' 'K'],D,Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1
166,5BVP,H,52,52,IGHV3-33,W,['W' 'S'],S,"The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",interleukin-1 beta,I,homo sapiens
167,5BVP,H,94,98,IGHV3-33,R,['R' 'K'],K,"The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",interleukin-1 beta,I,homo sapiens
168,2XTJ,D,54,55,IGHV1-69,L,['F' 'L'],F,The crystal structure of PCSK9 in complex with 1D05 Fab,proprotein convertase subtilisin/kexin type 9,A,homo sapiens
169,2XTJ,D,56,57,IGHV1-69,I,['T' 'I'],T,The crystal structure of PCSK9 in complex with 1D05 Fab,proprotein convertase subtilisin/kexin type 9,A,homo sapiens
170,8GV5,C,52,82,IGHV3-30,S,['S' 'R'],R,Crystal structure of PN-SIA28 in complex with influenza hemagglutinin A/swine/Guangdong/104/2013 (H1N1),hemagglutinin ha2 chain | hemagglutinin ha1 chain,B | A,influenza a virus(a/swine/guangdong/104/2013(h1n1))  | influenza a virus(a/swine/guangdong/104/2013(h1n1)) 
171,8GV7,C,52,82,IGHV3-30,S,['S' 'R'],R,Crystal structure of PN-SIA28 in complex with influenza hemagglutinin H18 A/flat-faced bat/Peru/033/2010,hemagglutinin h18-ha2 | hemagglutinin h18-ha1,B | A,influenza a virus (a/flat-facedbat/peru/033/2010(h18n11))  | influenza a virus (a/flat-facedbat/peru/033/2010(h18n11)) 
172,4S1Q,H,50,50,IGHV1-2,W,['R' 'W'],R,"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core",hiv-1 gp120 core,G,homo sapiens
173,4S1Q,H,69,69,IGHV1-2,M,['S' 'M'],S,"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core",hiv-1 gp120 core,G,homo sapiens
174,4S1R,H,50,50,IGHV1-2,W,['R' 'W'],R,"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H08.F-117225, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
175,4S1S,H,50,50,IGHV1-2,W,['R' 'W'],R,"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H5.F-185917, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
176,7E3O,H,26,26,IGHV3-30,G,['G' 'A'],A,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
177,7E3O,H,94,97,IGHV3-30,R,['R' 'K'],K,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
178,3SE9,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1
179,5J13,B,50,52,IGLV3-21,D,['Y' 'D'],Y,Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens
180,5J13,C,52,55,IGHV3-33,W,['W' 'S'],S,Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens
181,5J13,C,94,101,IGHV3-33,R,['R' 'K'],K,Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens
182,4AL8,L,30,30,IGKV1-17,R,['R' 'S'],S,Structure of Dengue virus DIII in complex with Fab 2H12,envelope protein,C,dengue virus
183,5C0S,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261,"hemagglutinin, envelope glycoprotein, fibritin fusionprotein ",A,"influenza a virus, human immunodeficiency virustype 1 group m subtype b, enterobacteria phage t4 "
184,5C0S,H,56,56,IGHV1-69,T,['T' 'I'],I,Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261,"hemagglutinin, envelope glycoprotein, fibritin fusionprotein ",A,"influenza a virus, human immunodeficiency virustype 1 group m subtype b, enterobacteria phage t4 "
185,4DN4,H,54,55,IGHV1-69,F,['F' 'L'],L,Crystal structure of the complex between cnto888 fab and mcp-1 mutant p8a,c-c motif chemokine 2,M,homo sapiens
186,7T01,H,54,56,IGHV2-5,D,['N' 'D'],N,SARS-CoV-2 S-RBD + Fab 54042-4,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
187,7LY0,H,31,31,IGHV3-33,S,['S' 'R'],R,SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
188,7LY0,H,35,35,IGHV3-33,H,['H' 'Y'],Y,SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
189,7LY0,H,52,52,IGHV3-33,W,['W' 'S'],S,SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
190,4J6R,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120,envelope glycoprotein gp160,G,human immunodeficiency virus 1
191,3U7Y,H,50,50,IGHV1-2,W,['R' 'W'],R,Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV,envelope glycoprotein gp160,G,human immunodeficiency virus 1
192,3U7Y,H,69,69,IGHV1-2,M,['S' 'M'],S,Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV,envelope glycoprotein gp160,G,human immunodeficiency virus 1
193,3MLZ,H,30,30,IGHV4-59,S,['S' 'Y'],Y,Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1
194,3MLZ,H,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1
195,3MLZ,L,50,50,IGLV1-51,E,['D' 'E'],D,Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1
196,6IUT,H,31,30,IGHV4-4,S,['S' 'N'],N,Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1))
197,6IUT,H,50,49,IGHV4-4,Y,['E' 'R' 'Y'],E,Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1))
198,6IUT,H,50,49,IGHV4-4,Y,['E' 'R' 'Y'],R,Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1))
199,6IUT,H,73,72,IGHV4-4,T,['K' 'T'],K,Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1))
200,7ND3,H,54,54,IGHV3-66,G,['G' 'C'],C,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
201,7V27,A,32,34,IGLV2-14,Y,['Y' 'L'],L,RBD/XG005 local refinement,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
202,7V27,B,54,56,IGHV2-5,D,['N' 'D'],N,RBD/XG005 local refinement,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
203,7SD5,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
204,7SD5,H,26,26,IGHV4-39,G,['G' 'S'],S,Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
205,7SD5,H,27,27,IGHV4-39,G,['G' 'Y'],Y,Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
206,7SD5,H,28,28,IGHV4-39,S,['S' 'Y'],Y,Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
207,7OXN,H,31,31,IGHV3-33,S,['S' 'R'],R,Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
208,7OXN,H,35,35,IGHV3-33,H,['H' 'Y'],Y,Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
209,7OXN,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
210,7T72,H,54,54,IGHV3-66,G,['G' 'C'],C,Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
211,7T73,H,52C,52C,IGHV3-15,T,['T' 'A'],A,HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab,hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
212,7T73,H,53,53,IGHV3-15,D,['D' 'N'],N,HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab,hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
213,7T76,H,26,26,IGHV3-30,G,['G' 'A'],A,HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab,hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
214,7T76,H,94,94,IGHV3-30,R,['R' 'K'],K,HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab,hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
215,7T77,H,26,26,IGHV3-30,G,['G' 'A'],A,HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab,hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1
216,6DB6,H,51,51,IGHV1-3,I,['I' 'S'],S,Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain,hiv-1 gp120 v3 peptide from mn strain,P,human immunodeficiency virus 1
217,6DB6,L,50,50,IGLV3-10,E,['E' 'K'],K,Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain,hiv-1 gp120 v3 peptide from mn strain,P,human immunodeficiency virus 1
218,7KQL,H,30,30,IGHV4-39,S,['S' 'G'],G,Anti-Tim3 antibody Fab complex,hepatitis a virus cellular receptor 2,T,homo sapiens
219,3N85,H,58,58,IGHV3-74,S,['S' 'T'],T,Crystallographic trimer of HER2 extracellular regions in complex with tryptophan-rich antibody fragment,receptor tyrosine-protein kinase erbb-2,A,homo sapiens
220,6WG0,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of Fab366 in complex with NPNA3 peptide from circumsporozoite protein,npna3 peptide,P,plasmodium falciparum
221,6WGL,A,52,52,IGHV3-23,S,['S' 'Y'],Y,Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor,interleukin-4 receptor subunit alpha,C,homo sapiens
222,6WGL,A,53,54,IGHV3-23,S,['S' 'G'],G,Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor,interleukin-4 receptor subunit alpha,C,homo sapiens
223,7MDP,H,26,26,IGHV4-4,G,['G' 'S'],S,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
224,7MDP,H,27,27,IGHV4-4,G,['G' 'I'],I,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
225,7MDP,H,31,31,IGHV4-4,S,['S' 'N'],N,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
226,7MDP,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
227,7MDP,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
228,7MDP,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],W,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
229,7MDP,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],Y,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
230,7MDP,H,53,53,IGHV4-4,H,['H' 'T'],T,KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens
231,6XZW,L,60,61,IGKV3-20,D,['D' 'A'],A,Crystal structure of the meningococcal vaccine antigen fHbp in complex with a cross-reactive human Fab.,lipoprot_c domain-containing protein,D,neisseria meningitidis serogroup b (strainmc58) 
232,4XI5,D,33,33,IGHV3-30,A,['A' 'G'],G,gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine
233,4XI5,D,50,50,IGHV3-30,V,['V' 'F'],F,gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine
234,4XI5,D,52,52,IGHV3-30,S,['S' 'R'],R,gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine
235,7ZR8,H,33,33,IGHV1-69,T,['A' 'T'],A,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 "
236,7ZR8,H,50,50,IGHV1-69,R,['G' 'R'],G,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 "
237,7ZR8,H,73,74,IGHV1-69,K,['E' 'K'],E,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 "
238,7ZR8,L,50,50,IGKV1-5,D,['D' 'K'],K,OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 "
239,7B3O,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 
240,6VJT,H,31,31,IGHV3-33,R,['S' 'R'],S,Co-crystals of broadly neutralizing antibody with the linear epitope from Hepatitis B surface antigen,antigenic region 139-148 of hepatitis b surface antigenprotein ,P,hepatitis b virus
241,6VJT,H,52,52,IGHV3-33,W,['W' 'S'],S,Co-crystals of broadly neutralizing antibody with the linear epitope from Hepatitis B surface antigen,antigenic region 139-148 of hepatitis b surface antigenprotein ,P,hepatitis b virus
242,6ULF,A,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of 4498 Fab in complex with circumsporozoite protein NDN3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library
243,6ULC,H,26,26,IGHV3-30,G,['G' 'A'],A,"Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom","envelope glycoprotein gp120,envelope glycoprotein gp120 | envelope glycoprotein gp120,envelope glycoprotein gp120",A | E,human immunodeficiency virus 1 | human immunodeficiency virus 1
244,7YKJ,D,60,61,IGKV3-20,D,['D' 'A'],A,Omicron RBDs bound with P3E6 Fab (one up and one down),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
245,7T5O,L,50,49,IGLV3-21,D,['Y' 'D'],Y,VFLIP Spike Trimer with GAR03,spike glycoprotein,C,severe acute respiratory syndrome-relatedcoronavirus 
246,7M71,H,50,50,IGHV3-30,V,['V' 'F'],F,SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
247,7M71,H,52,52,IGHV3-30,S,['S' 'R'],R,SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
248,7M71,H,94,98,IGHV3-30,R,['R' 'K'],K,SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
249,6MLK,H,30,32,IGHV4-34,S,['S' 'Y'],Y,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
250,6MLK,H,31,33,IGHV4-34,G,['G' 'W'],W,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
251,6MLK,H,32,34,IGHV4-34,Y,['Y' 'S'],S,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
252,6MLK,H,52,54,IGHV4-34,N,['N' 'Y' 'I'],Y,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
253,6MLK,H,52,54,IGHV4-34,N,['N' 'Y' 'I'],I,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
254,6MLK,H,53,55,IGHV4-34,H,['H' 'Y'],Y,Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea
255,7D5B,D,58,218,IGHV3-74,T,['S' 'T'],S,"BACE2 xaperone complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide",beta-secretase 2,A,homo sapiens
256,7D5U,D,58,218,IGHV3-74,T,['S' 'T'],S,"BACE2 xaperone complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide",beta-secretase 2,A,homo sapiens
257,7EY4,H,58,59,IGHV3-11,Y,['Y' 'N'],N,Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667,spike glycoprotein | ntd,R | N,severe acute respiratory syndrome coronavirus2  | homo sapiens
258,6E4X,Z,34,34,IGHV4-61,Y,['Y' 'W'],W,Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2),hemagglutinin,B,influenza a virus (a/texas/50/2012(h3n2))
259,2EKS,B,31,31,IGHV4-59,S,['S' 'Y'],Y,Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus
260,2EKS,B,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus
261,2EKS,B,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus
262,2EKS,B,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus
263,2EKS,B,58,58,IGHV4-59,Y,['N' 'Y'],N,Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus
264,7SJS,H,50,50,IGHV3-23,A,['A' 'V'],V,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
265,7SJS,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
266,7SJS,H,53,53,IGHV3-23,G,['S' 'G'],S,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
267,7SJS,H,55,55,IGHV3-23,G,['G' 'S'],S,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
268,7SJS,L,50,50,IGLV3-10,E,['E' 'K'],K,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
269,7SJS,L,96,96,IGLV3-10,A,['T' 'A'],T,Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 
270,4OT1,L,50,51,IGLV1-51,D,['D' 'E'],E,Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by the Neutralizing Human Antibody SM5-1,envelope glycoprotein b,A,human cytomegalovirus
271,7VNG,L,90,90,IGKV1-39,Q,['Q' 'C'],C,Crystal structure of human coronavirus 229E spike protein receptor-binding domain in complex with S11 Fab,spike glycoprotein s1,D,human coronavirus 229e
272,4HHA,B,33,33,IGHV3-30,G,['A' 'G'],A,Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5
273,4HHA,B,52,52,IGHV3-30,S,['S' 'R'],R,Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5
274,4HHA,B,94,94,IGHV3-30,R,['R' 'K'],K,Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5
275,6PZE,L,50,50,IGLV1-51,D,['D' 'E'],E,Crystal structure of human NA-45 Fab in complex with neuraminidase Y169aH mutant from A/Shanghai/2/2013 (H7N9),neuraminidase,A,influenza a virus (a/shanghai/02/2013(h7n9))
276,6B0G,C,27D,27D,IGKV2-30,Y,['Y' 'H'],H,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1245,25 kda ookinete surface antigen,E,plasmodium falciparum
277,6B0A,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum
278,6B0A,H,52A,53,IGHV3-23,G,['G' 'S'],S,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum
279,6B0A,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum
280,6B08,B,50,50,IGLV3-21,Y,['Y' 'D'],D,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1276,pfs25,A,plasmodium falciparum
281,6B08,C,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of Pfs25 in complex with the transmission blocking antibody 1276,pfs25,A,plasmodium falciparum
282,7MF1,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
283,7MF1,H,73,73,IGHV1-69,E,['E' 'K'],K,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
284,7MF1,L,50,50,IGLV2-14,D,['E' 'D'],E,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
285,6AOD,A,30,30,IGKV1-17,R,['R' 'S'],S,FXIa antibody complex,coagulation factor xi,C,homo sapiens
286,6AOD,A,32,32,IGKV1-17,D,['D' 'Y'],Y,FXIa antibody complex,coagulation factor xi,C,homo sapiens
287,6AOD,A,34,34,IGKV1-17,G,['G' 'A'],A,FXIa antibody complex,coagulation factor xi,C,homo sapiens
288,6AOD,B,50,50,IGHV1-2,W,['R' 'W'],R,FXIa antibody complex,coagulation factor xi,C,homo sapiens
289,6AOD,B,61,62,IGHV1-2,Q,['Q' 'H'],H,FXIa antibody complex,coagulation factor xi,C,homo sapiens
290,3PGF,H,54,54,IGHV3-11,S,['G' 'S'],G,Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB),maltose-binding periplasmic protein,A,escherichia coli
291,3PGF,H,56,56,IGHV3-11,Y,['T' 'Y'],T,Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB),maltose-binding periplasmic protein,A,escherichia coli
292,6FGB,H,26,26,IGHV3-30,G,['G' 'A'],A,Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens
293,6FGB,L,32,37,IGKV1-17,Y,['D' 'Y'],D,Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens
294,3GRW,H,52,52,IGHV3-23,Y,['S' 'Y'],S,FGFR3 in complex with a Fab,fibroblast growth factor receptor 3,A,homo sapiens
295,7VNC,V,52,52,IGHV3-23,Y,['S' 'Y'],S,"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)",spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
296,7VNB,A,52,52,IGHV3-23,Y,['S' 'Y'],S,Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113,spike protein s1,B,severe acute respiratory syndrome coronavirus2 
297,5CIN,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1
298,5CIN,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1
299,5CIN,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1
300,5CIN,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1
301,5CIL,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1
302,5CIL,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1
303,5CIL,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1
304,5CIL,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1
305,6VJN,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens
306,6VJN,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens
307,6VJN,H,50,50,IGHV4-59,R,['Y' 'R'],Y,Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens
308,6VJN,H,58,58,IGHV4-59,Y,['N' 'Y'],N,Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens
309,7FCQ,L,50,52,IGLV2-14,E,['E' 'D'],D,Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
310,7F62,H,56,57,IGHV3-11,Y,['T' 'Y'],T,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
311,7F62,H,58,59,IGHV3-11,N,['Y' 'N'],Y,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
312,7F62,L,96,97,IGKV3D-20,Y,['Y' 'R'],R,Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
313,5GGT,H,54,55,IGHV1-69,F,['F' 'L'],L,PD-L1 in complex with BMS-936559 Fab,programmed cell death 1 ligand 1,A,homo sapiens
314,5GGV,H,52,52,IGHV3-33,W,['W' 'S'],S,CTLA-4 in complex with tremelimumab Fab,cytotoxic t-lymphocyte protein 4,Y,homo sapiens
315,2WUC,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp and Ac-KQLR-chloromethylketone,hepatocyte growth factor activator long chain,A,homo sapiens
316,6DFI,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus
317,6DFI,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus
318,6DFI,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus
319,6DFJ,H,27,27,IGHV4-59,G,['G' 'I'],I,Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1
320,6DFJ,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1
321,6DFJ,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1
322,6DFJ,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1
323,7LSS,H,54,54,IGHV2-5,D,['N' 'D'],N,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
324,7LSS,L,32,32,IGLV2-14,Y,['Y' 'L'],L,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
325,7LSS,L,50,50,IGLV2-14,D,['E' 'D'],E,Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
326,1U8P,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ECDKWCS,gp41 peptide,C,human immunodeficiency virus 1
327,1U8Q,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELEKWAS,gp41 peptide,C,human immunodeficiency virus 1
328,1U8J,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWAG,gp41 peptide,C,human immunodeficiency virus 1
329,1U8K,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LELDKWASL,gp41 peptide,C,human immunodeficiency virus 1
330,1U8H,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWAS,gp41 peptide,C,human immunodeficiency virus 1
331,1U8I,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWAN,gp41 peptide,C,human immunodeficiency virus 1
332,1U8N,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKFAS,gp41 peptide,C,human immunodeficiency virus 1
333,1U8O,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKHAS,gp41 peptide,C,human immunodeficiency virus 1
334,1U8L,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide DLDRWAS,gp41 peptide,C,human immunodeficiency virus 1
335,7SN2,H,52,52,IGHV3-33,W,['W' 'S'],S,Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
336,6OZ2,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of the broadly neutralizing antibody N49P6 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
337,7WBZ,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
338,4R8W,L,60,61,IGKV3-20,D,['D' 'A'],A,Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a neutralizing antibody CT149,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/anhui/1-balf_rg45/2013(h7n9))  | influenza a virus (a/anhui/1-balf_rg45/2013(h7n9)) 
339,5HHV,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens
340,5HHV,H,53,53,IGHV3-23,S,['S' 'G'],G,Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens
341,5HHV,H,55,55,IGHV3-23,G,['G' 'S'],S,Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens
342,5HHX,H,53,53,IGHV3-23,S,['S' 'G'],G,Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens
343,5HHX,H,55,55,IGHV3-23,G,['G' 'S'],S,Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens
344,1U8M,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKYAS,gp41 peptide,C,human immunodeficiency virus 1
345,2B1H,L,50,50,IGLV1-47,R,['R' 'S'],S,Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG29 peptide,ug29 peptide of exterior membrane glycoprotein gp120,P,
346,5Y2L,I,26,45,IGHV3-30,G,['G' 'A'],A,Crystal structure of a group 2 HA binding antibody AF4H1K1 Fab in complex with the 1968 H3N2 pandemic (H3-AC/68) hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (strain a/aichi/2/1968 h3n2) | influenza a virus (strain a/aichi/2/1968 h3n2)
347,2EIZ,B,31,31,IGHV4-59,S,['S' 'Y'],Y,Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus
348,2EIZ,B,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus
349,2EIZ,B,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus
350,2EIZ,B,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus
351,2EIZ,B,58,58,IGHV4-59,Y,['N' 'Y'],N,Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus
352,7FG2,D,52,53,IGHV3-23,S,['S' 'Y'],Y,"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
353,7FG2,D,60,62,IGHV3-23,G,['A' 'G'],A,"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
354,7FG3,D,52,53,IGHV3-23,S,['S' 'Y'],Y,"Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
355,7Z0Y,H,33,33,IGHV3-30,A,['A' 'G'],G,THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
356,7Z0Y,H,50,50,IGHV3-30,V,['V' 'F'],F,THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
357,7Z0Y,H,52,52,IGHV3-30,S,['S' 'R'],R,THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
358,4G7V,L,30,30,IGKV1-13,S,['I' 'S'],I,"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.5 A)",voltage-sensor containing phosphatase,S,ciona intestinalis
359,4G7V,L,32,32,IGKV1-13,A,['S' 'A'],S,"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.5 A)",voltage-sensor containing phosphatase,S,ciona intestinalis
360,4NGH,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,
361,4NGH,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,
362,4NGH,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,
363,4JKP,H,50,50,IGHV1-2,W,['R' 'W'],R,Restricting HIV-1 Pathways for Escape using Rationally-Designed Anti-HIV-1 Antibodies,gp120,G,human immunodeficiency virus 1
364,7RU4,H,33,33,IGHV1-69,A,['A' 'T'],T,CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
365,7RU4,H,54,54,IGHV1-69,L,['F' 'L'],F,CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
366,7RU4,H,56,56,IGHV1-69,I,['T' 'I'],T,CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
367,7RU4,H,73,73,IGHV1-69,K,['E' 'K'],E,CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
368,6CBV,H,54,58,IGHV3-48,S,['S' 'G'],G,Crystal strutcure of BRIL bound to an affinity matured synthetic antibody.,bril,B,escherichia coli
369,5X08,H,33,33,IGHV1-69,A,['A' 'T'],T,"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) 
370,5X08,H,50,50,IGHV1-69,G,['G' 'R'],R,"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) 
371,5X08,H,54,54,IGHV1-69,L,['F' 'L'],F,"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) 
372,5X08,H,56,56,IGHV1-69,I,['T' 'I'],T,"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) 
373,7LQW,H,54,54,IGHV1-69,F,['F' 'L'],L,Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
374,7LQW,H,56,56,IGHV1-69,T,['T' 'I'],I,Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
375,7TAS,H,52A,53,IGHV3-43,W,['W' 'G'],G,SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146),spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 
376,5L6Y,L,50,50,IGLV3-21,D,['Y' 'D'],Y,il13 in complex with tralokinumab,interleukin-13,C,homo sapiens
377,8DWA,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
378,5UWE,H,54,54,IGHV1-69,F,['F' 'L'],L,"CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1",clade a/e 93th057 hiv-1 gp120 core | m48u1 cd4 mimetic peptide,G | N,human immunodeficiency virus 1 | synthetic construct
379,4G7Y,L,30,30,IGKV1-13,S,['I' 'S'],I,"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.8 A)",voltage-sensor containing phosphatase,S,ciona intestinalis
380,4G7Y,L,32,32,IGKV1-13,A,['S' 'A'],S,"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.8 A)",voltage-sensor containing phosphatase,S,ciona intestinalis
381,4DAG,H,54,54,IGHV3-66,G,['G' 'C'],C,Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneumovirus Antigenic Site,fusion glycoprotein f0,A,human metapneumovirus
382,7WP5,H,94,98,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 Omicron S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spikeprotein s1,F,severe acute respiratory syndrome coronavirus2 
383,6JSZ,D,58,218,IGHV3-74,T,['S' 'T'],S,"BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide",beta-secretase 2,A,homo sapiens
384,6UJ9,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens
385,6UJ9,H,53,54,IGHV3-23,G,['S' 'G'],S,Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens
386,6MJZ,H,31,31,IGHV4-59,S,['S' 'Y'],Y,Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3
387,6MJZ,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3
388,6MJZ,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3
389,6MJZ,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3
390,6MJZ,H,53,53,IGHV4-59,Y,['Y' 'T'],T,Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3
391,6W4M,H,54,54,IGHV1-69,F,['F' 'L'],L,"CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1",clade a/e 93th057 hiv-1 gp120 core | m48u1 cd4 mimetic peptide,G | N,human immunodeficiency virus 1 | synthetic construct
392,5ERW,A,50,50,IGHV1-69,G,['G' 'R'],R,Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus
393,5ERW,A,54,55,IGHV1-69,F,['F' 'L'],L,Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus
394,5ERW,A,56,57,IGHV1-69,T,['T' 'I'],I,Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus
395,5ERW,B,50,49,IGLV3-21,D,['Y' 'D'],Y,Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus
396,7M7B,H,53,53,IGHV4-34,H,['H' 'Y'],Y,SARS-CoV-2 Spike:Fab 3D11 complex focused refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
397,7M7E,C,31,33,IGHV3-49,D,['D' 'Y'],Y,6-Deoxyerythronolide B synthase (DEBS) hybrid module (M3/1) in complex with antibody fragment 1B2,"6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera  | 6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera ",A | B,saccharopolyspora erythraea | saccharopolyspora erythraea
398,7M7E,C,33,35,IGHV3-49,A,['A' 'P'],P,6-Deoxyerythronolide B synthase (DEBS) hybrid module (M3/1) in complex with antibody fragment 1B2,"6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera  | 6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera ",A | B,saccharopolyspora erythraea | saccharopolyspora erythraea
399,4XAW,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1
400,4XAW,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1
401,4XAW,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1
402,4XAW,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1
403,7THE,B,50,50,IGHV1-69,R,['G' 'R'],G,Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
404,7THE,B,54,54,IGHV1-69,F,['F' 'L'],L,Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
405,7THE,B,56,56,IGHV1-69,I,['T' 'I'],T,Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
406,7THE,B,73,73,IGHV1-69,K,['E' 'K'],E,Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
407,8DXT,H,52A,53,IGHV3-23,G,['G' 'S'],S,Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
408,8DXT,H,53,54,IGHV3-23,S,['S' 'G'],G,Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
409,8DXT,H,55,56,IGHV3-23,G,['G' 'S'],S,Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
410,8DXT,L,50,50,IGKV1-5,D,['D' 'K'],K,Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 
411,7YXU,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens
412,7YXU,H,52A,53,IGHV3-23,S,['G' 'S'],G,Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens
413,7YXU,H,53,54,IGHV3-23,G,['S' 'G'],S,Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens
414,2XQB,L,50,50,IGLV1-47,R,['R' 'S'],S,Crystal Structure of anti-IL-15 Antibody in Complex with human IL-15,interleukin 15,A,homo sapiens
415,5F9O,H,30,30,IGHV1-46,N,['T' 'N'],T,Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.09 in complex with HIV-1 clade A/E 93TH057 gp120,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
416,4HF5,H,31,31,IGHV3-33,S,['S' 'R'],R,Crystal structure of Fab 8F8 in complex a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus
417,3FN0,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,
418,3FN0,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,
419,3FN0,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,
420,3FN0,H,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,
421,6OZ9,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],S,Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus
422,6OZ9,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],W,Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus
423,6OZ9,H,50,50,IGHV4-4,Y,['E' 'R' 'Y'],E,Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus
424,6OZ9,H,50,50,IGHV4-4,Y,['E' 'R' 'Y'],R,Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus
425,7RQQ,H,52,52,IGHV3-33,W,['W' 'S'],S,Structure of chimeric antibody F10heavy_L9light with PfCSP peptide NANPNVDP,pfcsp peptide nanpnvdp,P,plasmodium falciparum 3d7
426,7N3D,H,31,31,IGHV4-59,S,['S' 'Y'],Y,Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
427,7N3D,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
428,7N3D,H,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
429,5F96,H,30,30,IGHV1-46,N,['T' 'N'],T,Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.12 in complex with HIV-1 clade A/E 93TH057 gp120,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
430,4KHT,H,33,33,IGHV1-69,A,['A' 'T'],T,Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1
431,4KHT,H,54,54,IGHV1-69,F,['F' 'L'],L,Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1
432,4KHT,H,56,56,IGHV1-69,T,['T' 'I'],I,Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1
433,4KHX,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1
434,4KHX,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1
435,4HFU,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus
436,4HFU,H,73,73,IGHV1-69,E,['E' 'K'],K,Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus
437,7CR5,H,50,50,IGHV3-30,V,['V' 'F'],F,Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD,nucleoprotein,A,severe acute respiratory syndrome coronavirus2 
438,7CR5,H,52,52,IGHV3-30,S,['S' 'R'],R,Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD,nucleoprotein,A,severe acute respiratory syndrome coronavirus2 
439,6VBO,L,27D,27D,IGKV2-30,H,['Y' 'H'],Y,Crystal structure of anti-HIV-1 antibody DH813 bound to gp120 V2 peptide,envelope glycoprotein gp160,C,human immunodeficiency virus 1
440,5WHK,H,52A,53,IGHV3-23,S,['G' 'S'],G,Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens
441,5WHK,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens
442,5WHK,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens
443,7DJZ,A,50,50,IGHV1-69,R,['G' 'R'],G,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
444,7DJZ,A,54,55,IGHV1-69,L,['F' 'L'],F,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
445,7DJZ,A,56,57,IGHV1-69,I,['T' 'I'],T,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
446,7DJZ,A,73,74,IGHV1-69,K,['E' 'K'],E,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
447,2NXZ,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
448,7UAQ,H,54,54,IGHV3-48,G,['S' 'G'],S,"Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
449,5DWU,H,52A,53,IGHV3-23,S,['G' 'S'],G,Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens
450,5DWU,H,53,54,IGHV3-23,S,['S' 'G'],G,Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens
451,5DWU,H,55,56,IGHV3-23,G,['G' 'S'],S,Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens
452,5XKU,C,33,29,IGHV4-31,G,['G' 'S'],S,Crystal structure of hemagglutinin globular head from an H7N9 influenza virus in complex with a neutralizing antibody HNIgGA6,influenza a virus,A,influenza a virus
453,6YWD,A,33,41,IGHV2-70,G,['G' 'E'],E,De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct
454,6YWD,A,58,68,IGHV2-70,H,['Y' 'F' 'H'],Y,De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct
455,6YWD,A,58,68,IGHV2-70,H,['Y' 'F' 'H'],F,De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct
456,6YWD,B,50,57,IGKV1-5,D,['D' 'K'],K,De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct
457,6DC3,L,29,29,IGLV2-14,G,['G' 'S'],S,RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified "
458,6DC3,L,32,32,IGLV2-14,Y,['Y' 'L'],L,RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified "
459,6DC3,L,50,50,IGLV2-14,D,['E' 'D'],E,RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified "
460,6DC3,L,51,51,IGLV2-14,V,['V' 'G'],G,RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified "
461,4PS4,H,54,56,IGHV2-5,D,['N' 'D'],N,Crystal structure of the complex between IL-13 and M1295 FAB,interleukin-13,A,homo sapiens
462,6XPY,B,26,26,IGHV4-4,G,['G' 'S'],S,Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus
463,6XPY,B,27,27,IGHV4-4,G,['G' 'I'],I,Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus
464,6XPY,B,32,32,IGHV4-4,Y,['S' 'W' 'Y'],S,Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus
465,6XPY,B,32,32,IGHV4-4,Y,['S' 'W' 'Y'],W,Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus
466,6XPQ,B,2,2,IGHV4-61,V,['V' 'L'],L,Human antibody D1 H1-17/H3-14 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus (a/texas/50/2012(h3n2))
467,4XC1,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
468,4XC1,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
469,4XC1,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
470,4XC1,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
471,4XC3,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
472,4XC3,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
473,4XC3,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
474,4XC3,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1
475,6IW0,H,26,27,IGHV4-59,G,['G' 'S'],S,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
476,6IW0,H,27,28,IGHV4-59,G,['G' 'I'],I,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
477,6IW0,H,30,31,IGHV4-59,Y,['S' 'Y'],S,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
478,6IW0,H,32,33,IGHV4-59,H,['Y' 'W' 'H'],Y,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
479,6IW0,H,32,33,IGHV4-59,H,['Y' 'W' 'H'],W,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
480,6IW0,H,53,54,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine)
481,6U1N,L,30,31,IGKV1-13,S,['I' 'S'],I,GPCR-Beta arrestin structure in lipid bilayer,"beta-arrestin-1 | muscarinic acetylcholine receptor m2, vasopressin v2receptor chimera ",C | R,rattus norvegicus | homo sapiens
482,6U1N,L,32,33,IGKV1-13,A,['S' 'A'],S,GPCR-Beta arrestin structure in lipid bilayer,"beta-arrestin-1 | muscarinic acetylcholine receptor m2, vasopressin v2receptor chimera ",C | R,rattus norvegicus | homo sapiens
483,7OLY,H,28,28,IGHV4-39,S,['S' 'Y'],Y,Structure of activin A in complex with an ActRIIB-Alk4 fusion reveal insight into activin receptor interactions,activin receptor type-2b,C,homo sapiens
484,7OLY,H,30,30,IGHV4-39,S,['S' 'G'],G,Structure of activin A in complex with an ActRIIB-Alk4 fusion reveal insight into activin receptor interactions,activin receptor type-2b,C,homo sapiens
485,7WLC,H,33,33,IGHV1-69,T,['A' 'T'],A,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
486,7WLC,H,50,50,IGHV1-69,R,['G' 'R'],G,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
487,7RU8,H,33,33,IGHV1-69,A,['A' 'T'],T,CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
488,7RU8,H,50,50,IGHV1-69,G,['G' 'R'],R,CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
489,7AZB,B,52,74,IGHV3-23,S,['S' 'Y'],Y,Structure of DDR2 DS domain in complex with VHH,discoidin domain-containing receptor 2,A,homo sapiens
490,7AZB,B,60,84,IGHV3-23,A,['A' 'G'],G,Structure of DDR2 DS domain in complex with VHH,discoidin domain-containing receptor 2,A,homo sapiens
491,2XWT,B,50,50,IGLV1-51,D,['D' 'E'],E,Crystal structure of the TSH receptor in complex with a blocking type  TSHR autoantibody,thyrotropin receptor,C,homo sapiens
492,2NY6,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
493,2NY5,H,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,G,human immunodeficiency virus 1
494,2NY4,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
495,2NY1,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
496,2NY0,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
497,6QB6,H,50,50,IGHV3-21,S,['S' 'Y'],Y,Mcl1 in complex with a Fab,induced myeloid leukemia cell differentiation protein mcl-1 ,A,homo sapiens
498,6BCK,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal Structure of Broadly Neutralizing Antibody N49P7 in Complex with HIV-1 Clade AE strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
499,6MF7,H,51,52,IGHV4-30-4,I,['I' 'F'],F,Structure of parvovirus B19 decorated with Fab molecules from a human antibody,vp2,A,human parvovirus b19
500,7DHA,C,52,52,IGHV3-23,S,['S' 'Y'],Y,crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens
501,7DHA,C,52A,53,IGHV3-23,G,['G' 'S'],S,crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens
502,7DHA,C,53,54,IGHV3-23,S,['S' 'G'],G,crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens
503,7DHA,C,55,56,IGHV3-23,G,['G' 'S'],S,crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens
504,7K8U,H,26,26,IGHV4-34,G,['G' 'F'],F,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
505,7K8U,H,27,27,IGHV4-34,G,['G' 'S'],S,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
506,7K8U,H,28,28,IGHV4-34,S,['S' 'T' 'G'],T,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
507,7K8U,H,28,28,IGHV4-34,S,['S' 'T' 'G'],G,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
508,7K8U,H,31,31,IGHV4-34,G,['G' 'W'],W,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
509,7K8U,H,32,32,IGHV4-34,Y,['Y' 'S'],S,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
510,7K8U,H,50,50,IGHV4-34,E,['E' 'Y'],Y,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
511,7K8U,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],Y,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
512,7K8U,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],I,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
513,7K8U,H,53,53,IGHV4-34,H,['H' 'Y'],Y,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
514,7K8Y,G,50,50,IGHV1-2,W,['R' 'W'],R,"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)",spike glycoprotein | spike glycoprotein,B | D,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
515,7L3N,D,33,33,IGHV1-69,A,['A' 'T'],T,SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
516,7L3N,D,50,50,IGHV1-69,R,['G' 'R'],G,SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
517,7L3N,D,54,55,IGHV1-69,L,['F' 'L'],F,SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
518,7L3N,D,56,57,IGHV1-69,I,['T' 'I'],T,SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
519,7L3N,D,73,74,IGHV1-69,K,['E' 'K'],E,SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
520,6W00,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum
521,4P59,H,50,50,IGHV3-23,A,['A' 'V'],V,HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens
522,4P59,H,52A,53,IGHV3-23,S,['G' 'S'],G,HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens
523,7UCX,L,27D,31,IGKV2-30,Y,['Y' 'H'],H,LRP8 11H1 Fab complexed to a cyclized CR1 peptide,cyclized cr1 peptide,B,homo sapiens
524,1ADQ,L,50,50,IGLV3-21,D,['Y' 'D'],Y,CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC,igg4 rea fc,A,homo sapiens
525,6XPX,B,50,50,IGHV3-30,V,['V' 'F'],F,Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2),hemagglutinin,A,influenza a virus
526,6XPX,B,52,52,IGHV3-30,S,['S' 'R'],R,Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2),hemagglutinin,A,influenza a virus
527,7YDY,H,33,33,IGHV1-69,A,['A' 'T'],T,SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
528,7YDY,H,54,55,IGHV1-69,L,['F' 'L'],F,SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
529,7YDY,H,56,57,IGHV1-69,I,['T' 'I'],T,SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
530,7YDY,H,73,74,IGHV1-69,K,['E' 'K'],E,SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
531,7YDY,L,69,71,IGLV1-40,T,['T' 'A'],A,SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
532,7YDI,H,33,33,IGHV1-69,A,['A' 'T'],T,"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 
533,7YDI,H,54,55,IGHV1-69,L,['F' 'L'],F,"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 
534,7YDI,H,56,57,IGHV1-69,I,['T' 'I'],T,"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 
535,7YDI,L,69,71,IGLV1-40,T,['T' 'A'],A,"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 
536,6Q18,H,26,26,IGHV4-4,G,['G' 'S'],S,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
537,6Q18,H,27,27,IGHV4-4,G,['G' 'I'],I,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
538,6Q18,H,31,31,IGHV4-4,S,['S' 'N'],N,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
539,6Q18,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
540,6Q18,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
541,6Q18,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],W,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
542,6Q18,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],Y,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
543,6Q18,H,34,34,IGHV4-4,W,['W' 'S'],S,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
544,6Q18,H,53,54,IGHV4-4,H,['H' 'T'],T,Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
545,6OCB,H,34,34,IGHV4-61,Y,['Y' 'W'],W,Crystal structure of FluA-20 Fab in complex with the head domain of H3 (A/Hong Kong/1/1968),hemagglutinin,A,influenza a virus
546,6VY6,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus
547,6VY6,H,52A,53,IGHV3-23,G,['G' 'S'],S,Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus
548,6VY6,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus
549,6VY6,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus
550,6VY5,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus
551,6VY5,H,52A,53,IGHV3-23,G,['G' 'S'],S,Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus
552,6VY5,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus
553,6VY5,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus
554,5GRJ,H,52,52,IGHV3-23,Y,['S' 'Y'],S,Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens
555,5GRJ,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens
556,5GRJ,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens
557,5GRJ,L,32,34,IGLV2-14,Y,['Y' 'L'],L,Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens
558,5GRJ,L,50,52,IGLV2-14,D,['E' 'D'],E,Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens
559,7XCP,H,31,31,IGHV3-13,S,['S' 'N'],N,Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab,spike protein s1,B,severe acute respiratory syndrome coronavirus2 
560,7XCP,H,57,57,IGHV3-13,T,['T' 'P'],P,Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab,spike protein s1,B,severe acute respiratory syndrome coronavirus2 
561,6GV4,H,52,52,IGHV3-23,S,['S' 'Y'],Y,High-resolution Cryo-EM of Fab-labeled human parechovirus 3,vp1 | vp0,B | A,human parechovirus 3 | human parechovirus 3
562,5T33,H,52,52,IGHV3-33,W,['W' 'S'],S,"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus
563,5T33,L,50,50,IGLV3-10,E,['E' 'K'],K,"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus
564,5CZV,H,33,33,IGHV1-69,T,['A' 'T'],A,Crystal structure of Notch3 NRR in complex with 20350 Fab,neurogenic locus notch homolog protein 3,A,homo sapiens
565,2H32,H,42,42,IGHV5-51,G,['G' 'R'],R,Crystal structure of the pre-B cell receptor,immunoglobulin omega chain,B,homo sapiens
566,2F5B,H,54,56,IGHV2-5,D,['N' 'D'],N,CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE,protein (gp41 epitope),P,
567,7WH8,B,50,50,IGHV1-69,R,['G' 'R'],G,SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
568,7WH8,B,54,55,IGHV1-69,F,['F' 'L'],L,SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
569,7WH8,B,56,57,IGHV1-69,T,['T' 'I'],I,SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
570,4FQY,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of broadly neutralizing antibody CR9114 bound to H3 influenza hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus
571,4FQI,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal Structure of Fab CR9114 in Complex with a H5N1 influenza virus hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus
572,6UYF,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1
573,5TE6,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
574,7STR,H,31,31,IGHV4-59,S,['S' 'Y'],Y,Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
575,7STR,H,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
576,7STR,H,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
577,7STR,H,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 
578,2NY2,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
579,5U3J,H,53,53,IGHV3-15,D,['D' 'N'],N,Crystal Structure of DH511.1 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1
580,5U3O,H,53,53,IGHV3-15,D,['D' 'N'],N,Crystal Structure of DH511.2_K3 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1
581,5U3N,H,53,53,IGHV3-15,D,['D' 'N'],N,Crystal Structure of DH511.12P Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1
582,5U3M,H,53,53,IGHV3-15,D,['D' 'N'],N,Crystal Structure of DH511.11P Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1
583,4UV7,H,52A,53,IGHV3-23,G,['G' 'S'],S,The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens
584,4UV7,H,53,54,IGHV3-23,G,['S' 'G'],S,The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens
585,4UV7,L,27D,31,IGKV2-30,H,['Y' 'H'],Y,The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens
586,5I8C,A,50,50,IGHV1-2,W,['R' 'W'],R,Crystal Structure of HIV-1 Clade A BG505 Fusion Peptide (residue 512-520) in Complex with Broadly Neutralizing Antibody VRC34.01 Fab,hiv-1 clade a bg505 fusion peptide (residue 512-520),C,human immunodeficiency virus 1
587,5WT9,H,52,52,IGHV3-33,W,['W' 'S'],S,Complex structure of PD-1 and nivolumab-Fab,programmed cell death protein 1,G,homo sapiens
588,2NY3,D,54,3055,IGHV1-69,L,['F' 'L'],F,"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1
589,3K2U,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of HGFA in complex with the allosteric inhibitory antibody Fab40,hepatocyte growth factor activator long chain,A,homo sapiens
590,7E23,B,23,23,IGHV4-34,A,['A' 'G'],G,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
591,7E23,B,24,24,IGHV4-34,V,['V' 'G'],G,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
592,7E23,B,25,25,IGHV4-34,Y,['Y' 'S'],S,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
593,7E23,B,26,26,IGHV4-34,G,['G' 'F'],F,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
594,7E23,B,29,29,IGHV4-34,F,['F' 'V' 'Y'],V,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
595,7E23,B,29,29,IGHV4-34,F,['F' 'V' 'Y'],Y,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
596,7E23,B,30,30,IGHV4-34,S,['S' 'Y'],Y,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
597,7E23,B,32,32,IGHV4-34,Y,['Y' 'S'],S,SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
598,7ZBU,H,33,33,IGHV3-30,G,['A' 'G'],A,CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
599,7ZBU,H,50,50,IGHV3-30,V,['V' 'F'],F,CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
600,7ZBU,H,52,52,IGHV3-30,S,['S' 'R'],R,CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
601,4WY7,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b 
602,4WY7,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b 
603,4WY7,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b 
604,4WY7,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b 
605,5XXY,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Complex structure of PD-L1 with atezolizumab Fab,programmed cell death 1 ligand 1,A,homo sapiens
606,5OCC,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens
607,5OCC,H,52A,53,IGHV3-23,G,['G' 'S'],S,Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens
608,5OCC,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens
609,5OCC,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens
610,7F9W,B,33,33,IGHV1-69,A,['A' 'T'],T,CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens
611,7F9W,B,50,50,IGHV1-69,R,['G' 'R'],G,CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens
612,7F9W,B,54,55,IGHV1-69,F,['F' 'L'],L,CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens
613,7LO8,H,52,78,IGHV3-23,S,['S' 'Y'],Y,NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus
614,7LO8,H,53,80,IGHV3-23,S,['S' 'G'],G,NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus
615,7LO8,L,90,114,IGKV1-39,Q,['Q' 'C'],C,NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus
616,4PY8,I,94,98,IGHV3-30,R,['R' 'K'],K,Crystal structure of Fab 3.1 in complex with the 1918 influenza virus hemagglutinin,hemagglutinin ha2 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus
617,4R4F,H,31,31,IGHV4-34,G,['G' 'W'],W,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
618,4R4F,H,50,50,IGHV4-34,E,['E' 'Y'],Y,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
619,4R4F,H,59,59,IGHV4-34,Y,['Y' 'N'],N,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
620,6VUG,D,52,55,IGHV3-33,W,['W' 'S'],S,Diabody bound to a Reverse Transcriptase Aptamer Complex,reverse transcriptase p51,B,human immunodeficiency virus 1
621,7OW1,H,31,31,IGHV3-33,S,['S' 'R'],R,Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
622,7OW1,H,35,35,IGHV3-33,H,['H' 'Y'],Y,Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
623,7OW1,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens
624,5GHW,H,50,50,IGHV3-15,R,['R' 'C'],C,Crystal structure of broad neutralizing antibody 10E8 with long epitope bound,endogenous retrovirus group k member 8 env polyprotein,P,human immunodeficiency virus 1
625,1GC1,H,54,55,IGHV1-69,L,['F' 'L'],F,HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY,envelope protein gp120,G,human immunodeficiency virus 1
626,5D70,H,52,52,IGHV3-23,S,['S' 'Y'],Y,"Crystal structure of MOR03929, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens
627,5D71,H,52,52,IGHV3-23,S,['S' 'Y'],Y,"Crystal structure of MOR04302, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens
628,3B2V,H,32,32,IGHV4-30-4,G,['G' 'Y'],Y,Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens
629,3B2V,H,33,33,IGHV4-30-4,D,['D' 'Y' 'G'],Y,Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens
630,3B2V,H,33,33,IGHV4-30-4,D,['D' 'Y' 'G'],G,Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens
631,3B2V,H,35,35,IGHV4-30-4,Y,['Y' 'S'],S,Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens
632,7L5B,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD).,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
633,7X92,H,52,52,IGHV3-33,W,['W' 'S'],S,The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
634,7ND8,H,56,57,IGHV3-11,T,['T' 'Y'],Y,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
635,7ND8,H,58,59,IGHV3-11,Y,['Y' 'N'],N,EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
636,7ND0,H,50,50,IGHV3-21,Y,['S' 'Y'],S,lateral-open conformation of the wild-type BAM complex (BamABCDE) bound to a bactericidal Fab fragment,outer membrane protein assembly factor bama,A,escherichia coli k-12
637,7WSL,H,52,52,IGHV3-23,S,['S' 'Y'],Y,PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens
638,7WSL,H,52A,53,IGHV3-23,G,['G' 'S'],S,PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens
639,7WSL,H,53,54,IGHV3-23,G,['S' 'G'],S,PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens
640,7WSL,H,55,56,IGHV3-23,S,['G' 'S'],G,PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens
641,5GJS,H,31,31,IGHV4-4,S,['S' 'N'],N,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
642,5GJS,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],S,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
643,5GJS,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],W,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
644,5GJS,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],N,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
645,5GJS,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],W,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
646,5GJS,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],E,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
647,5GJS,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],Y,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
648,5GJS,L,50,50,IGKV1-5,K,['D' 'K'],D,Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
649,5GJT,H,31,31,IGHV4-4,S,['S' 'N'],N,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
650,5GJT,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],S,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
651,5GJT,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],W,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
652,5GJT,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],N,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
653,5GJT,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],W,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
654,5GJT,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],E,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
655,5GJT,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],Y,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
656,5GJT,L,50,50,IGKV1-5,K,['D' 'K'],D,Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
657,2R0K,H,94,94,IGHV3-64,R,['R' 'K'],K,Protease domain of HGFA with inhibitor Fab58,hepatocyte growth factor activator,A,homo sapiens
658,7X26,H,50,50,IGHV1-69,R,['G' 'R'],G,S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 
659,7X26,H,54,55,IGHV1-69,L,['F' 'L'],F,S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 
660,7X26,H,56,57,IGHV1-69,I,['T' 'I'],T,S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 
661,7X26,H,73,74,IGHV1-69,K,['E' 'K'],E,S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 
662,6BKD,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1
663,6BKD,H,56,56,IGHV1-69,T,['T' 'I'],I,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1
664,4R4H,H,31,31,IGHV4-34,G,['G' 'W'],W,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
665,4R4H,H,50,50,IGHV4-34,E,['E' 'Y'],Y,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
666,4R4H,H,53,53,IGHV4-34,H,['H' 'Y'],Y,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
667,4R4H,H,59,59,IGHV4-34,Y,['Y' 'N'],N,"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1
668,7S0E,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
669,6BKC,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1
670,6BKB,H,54,54,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1
671,6BKB,H,56,56,IGHV1-69,T,['T' 'I'],I,Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1
672,3W9E,A,54,55,IGHV1-69,F,['F' 'L'],L,Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD,envelope glycoprotein d,C,human herpesvirus 2
673,3W9E,A,73,74,IGHV1-69,K,['E' 'K'],E,Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD,envelope glycoprotein d,C,human herpesvirus 2
674,7X2A,H,50,50,IGHV1-69,R,['G' 'R'],G,MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus 
675,7X2A,H,54,55,IGHV1-69,L,['F' 'L'],F,MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus 
676,7X2A,H,56,57,IGHV1-69,I,['T' 'I'],T,MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus 
677,7X2A,H,73,74,IGHV1-69,K,['E' 'K'],E,MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus 
678,3GBN,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal Structure of Fab CR6261 in Complex with the 1918 H1N1 influenza virus hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/brevigmission/1/1918(h1n1))  | influenza a virus (a/brevigmission/1/1918(h1n1)) 
679,3GBN,H,56,56,IGHV1-69,T,['T' 'I'],I,Crystal Structure of Fab CR6261 in Complex with the 1918 H1N1 influenza virus hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/brevigmission/1/1918(h1n1))  | influenza a virus (a/brevigmission/1/1918(h1n1)) 
680,3IDX,H,33,33,IGHV3-30,A,['A' 'G'],G,"Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222",hiv-1 hxbc2 gp120 core,G,human immunodeficiency virus 1
681,6Y97,H,50,50,IGHV1-69,R,['G' 'R'],G,Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens
682,6Y97,H,73,74,IGHV1-69,K,['E' 'K'],E,Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens
683,5CJQ,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of a trimeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114,"designed influenza hemagglutinin stem #4900, ha2 | designed influenza hemagglutinin stem #4900, ha1",B | A,synthetic construct | synthetic construct
684,6Y9A,H,50,50,IGHV1-69,R,['G' 'R'],G,Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens
685,5VOB,H,50,50,IGHV3-30,F,['V' 'F'],V,Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508)
686,5VOB,H,52,52,IGHV3-30,S,['S' 'R'],R,Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508)
687,5VOC,H,50,50,IGHV3-30,F,['V' 'F'],V,Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508)
688,5VOC,H,52,52,IGHV3-30,S,['S' 'R'],R,Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508)
689,5VOD,L,27D,31,IGKV2-30,Y,['Y' 'H'],H,Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6,envelope glycoprotein ul128 | envelope glycoprotein ul131a,C | E,human cytomegalovirus (strain ad169) | human cytomegalovirus (strain merlin)
690,7TPJ,H,94,101,IGHV3-64,R,['R' 'K'],K,Single-Particle Cryo-EM Structure of the WaaL O-antigen ligase in its apo state,putative cell surface polysaccharide polymerase/ligase,B,cupriavidus metallidurans
691,7ENF,P,52,52,IGHV3-30,S,['S' 'R'],R,Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
692,7ENG,H,52,52,IGHV3-30,S,['S' 'R'],R,Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 
693,7TPG,H,94,101,IGHV3-64,R,['R' 'K'],K,Single-Particle Cryo-EM Structure of the WaaL O-antigen ligase in its ligand bound state,putative cell surface polysaccharide polymerase/ligase,B,cupriavidus metallidurans
694,7X90,E,50,50,IGHV3-30,V,['V' 'F'],F,The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326,spike glycoprotein,G,severe acute respiratory syndrome coronavirus2 
695,7X90,E,52,52,IGHV3-30,S,['S' 'R'],R,The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326,spike glycoprotein,G,severe acute respiratory syndrome coronavirus2 
696,3IDI,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide ALDKWNQ,gp41 mper peptide,C,
697,3IDJ,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide analog ELD(Orn)WAS,gp41 mper peptide analog,C,
698,3IDN,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide analog ELD(Paf)WAS,gp41 mper peptide analog,C,
699,4O58,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of broadly neutralizing antibody F045-092 in complex with A/Victoria/3/1975 (H3N2) influenza hemagglutinin,hemagglutinin ha1 chain,A,influenza a virus
700,1G9N,H,54,55,IGHV1-69,L,['F' 'L'],F,HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1
701,6O39,B,52,52,IGHV3-23,Y,['S' 'Y'],S,Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens
702,6O39,B,52A,52A,IGHV3-23,S,['G' 'S'],G,Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens
703,6O39,B,53,53,IGHV3-23,S,['S' 'G'],G,Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens
704,6O39,B,55,55,IGHV3-23,G,['G' 'S'],S,Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens
705,6W05,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of Fab356 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum
706,7S6L,H,50,50,IGHV1-69,R,['G' 'R'],G,J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
707,7S6L,H,54,54,IGHV1-69,L,['F' 'L'],F,J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
708,7CM4,H,33,33,IGHV2-70,G,['G' 'E'],E,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
709,7CM4,H,58,60,IGHV2-70,Y,['Y' 'F' 'H'],F,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
710,7CM4,H,58,60,IGHV2-70,Y,['Y' 'F' 'H'],H,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
711,7CM4,H,64,66,IGHV2-70,K,['K' 'N'],N,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
712,7CM4,H,94,99,IGHV2-70,R,['R' 'H'],H,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
713,7CM4,L,50,51,IGLV1-51,D,['D' 'E'],E,Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
714,7VUX,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Complex structure of PD1 and 609A-Fab,programmed cell death protein 1,A,homo sapiens
715,7LCV,A,52,52,IGHV3-23,S,['S' 'Y'],Y,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
716,7LCV,A,53,54,IGHV3-23,S,['S' 'G'],G,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
717,7LCV,A,55,56,IGHV3-23,G,['G' 'S'],S,Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis
718,6OKM,H,30,30,IGHV1-46,T,['T' 'N'],N,Human OX40R (TNFRSF4) bound to Fab 3C8,tumor necrosis factor receptor superfamily member 4,R,homo sapiens
719,2P8L,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN,gp41 peptide,C,
720,2P8M,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN in new crystal form,gp41 peptide,C,
721,6O3A,B,50,50,IGHV3-21,Y,['S' 'Y'],S,Crystal structure of Frizzled 7 CRD in complex with F7.B Fab,frizzled-7,E,homo sapiens
722,2P8P,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LELDKWASLW[N-Ac],gp41 peptide,C,
723,5O4G,B,30,30,IGHV1-46,T,['T' 'N'],N,HER2 in complex with Fab MF3958,receptor tyrosine-protein kinase erbb-2,C,homo sapiens
724,7EPU,A,50,773,IGLV3-21,D,['Y' 'D'],Y,Crystal structure of HsALC1,chromodomain-helicase-dna-binding protein 1-like,B,homo sapiens
725,6D0X,A,31,31,IGHV3-33,S,['S' 'R'],R,Crystal structure of chimeric H.2140 / K.1210 Fab in complex with circumsporozoite protein NANP3,nanp3,C,plasmodium falciparum
726,6D0X,A,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of chimeric H.2140 / K.1210 Fab in complex with circumsporozoite protein NANP3,nanp3,C,plasmodium falciparum
727,7U8L,H,55,55,IGHV3-23,G,['G' 'S'],S,Crystal structure of chimeric hemagglutinin cH15/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus
728,7U8J,H,55,55,IGHV3-23,G,['G' 'S'],S,Crystal structure of chimeric hemagglutinin cH4/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus
729,2DD8,H,33,33,IGHV1-69,T,['A' 'T'],A,Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus
730,2DD8,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus
731,2DD8,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus
732,2DD8,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus
733,6NN3,H,66,68,IGHV4-31,R,['L' 'R'],L,Structure of parvovirus B19 decorated with Fab molecules from a human antibody,vp2 of b19 parvovirus,A,human parvovirus b19
734,7E8M,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
735,8DI5,H,52,52,IGHV3-23,Y,['S' 'Y'],S,Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 
736,7XW7,B,50,50,IGLV1-51,D,['D' 'E'],E,TSHR-K1-70 complex,thyrotropin receptor,R,homo sapiens
737,3EGS,B,54,56,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 scrambledFP-MPER scrHyb3K construct GIGAFGLLGFLAAGSKK-Ahx-K656NEQELLELDKWASLWN671 soaked in ammonium sulfate,gp41 scrfp-mper construct,C,
738,5UEK,L,30,30,IGKV1-13,S,['I' 'S'],I,Structure of antigen-Fab 12E complex with Histone chaperone ASF1,histone chaperone asf1,A,saccharomyces cerevisiae
739,5UEK,L,32,32,IGKV1-13,A,['S' 'A'],S,Structure of antigen-Fab 12E complex with Histone chaperone ASF1,histone chaperone asf1,A,saccharomyces cerevisiae
740,4XWG,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal Structure of LCAT (C31Y) in complex with Fab1,phosphatidylcholine-sterol acyltransferase,A,homo sapiens
741,6APB,H,33,33,IGHV2-70,G,['G' 'E'],E,Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus
742,6APB,H,50,50,IGHV2-70,R,['L' 'R'],L,Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus
743,6APB,H,58,58,IGHV2-70,Y,['Y' 'F' 'H'],F,Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus
744,6APB,H,58,58,IGHV2-70,Y,['Y' 'F' 'H'],H,Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus
745,5W42,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2),hemagglutinin,A,influenza a virus(a/swine/minnesota/a01134337/2010(h3n2)) 
746,2VH5,H,33,33,IGHV3-48,S,['S' 'E'],E,CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (disulfide free mutant)  COMPLEX,gtpase hras,R,homo sapiens
747,3Q1S,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],W,HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens
748,3Q1S,H,32,32,IGHV4-59,Y,['Y' 'W' 'H'],H,HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens
749,3Q1S,H,33,33,IGHV4-59,Y,['Y' 'S'],S,HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens
750,3Q1S,H,53,53,IGHV4-59,Y,['Y' 'T'],T,HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens
751,6U38,L,69,69,IGKV3-11,T,['T' 'R'],R,PCSK9 in complex with a Fab and compound 8,proprotein convertase subtilisin/kexin type 9,B,homo sapiens
752,7JV2,L,76,78,IGLV7-46,S,['S' 'L'],L,SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains),sars-cov-2 spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
753,7TTY,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1
754,7TTY,H,26,26,IGHV4-39,G,['G' 'S'],S,Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1
755,7TTY,H,27,27,IGHV4-39,G,['G' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1
756,7TTY,H,28,28,IGHV4-39,S,['S' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1
757,7TTY,H,30,30,IGHV4-39,S,['S' 'G'],G,Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1
758,7TTX,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13
759,7TTX,H,26,26,IGHV4-39,G,['G' 'S'],S,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13
760,7TTX,H,27,27,IGHV4-39,G,['G' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13
761,7TTX,H,28,28,IGHV4-39,S,['S' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13
762,7TTX,H,30,30,IGHV4-39,S,['S' 'G'],G,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13
763,7F15,B,51,51,IGHV1-3,I,['I' 'S'],S,A SARS-CoV-2 neutralizing antibody,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
764,3L5X,H,54,56,IGHV2-5,D,['N' 'D'],N,Crystal structure of the complex between IL-13 and H2L6 FAB,interleukin-13,A,homo sapiens
765,3L5Y,H,54,56,IGHV2-5,D,['N' 'D'],N,Crystal structure of the complex between IL-13 and M1295 FAB,interleukin-13,A,homo sapiens
766,4OQT,H,53,54,IGHV3-23,S,['S' 'G'],G,LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens
767,4OQT,H,55,56,IGHV3-23,G,['G' 'S'],S,LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens
768,7TTM,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014
769,7TTM,H,26,26,IGHV4-39,G,['G' 'S'],S,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014
770,7TTM,H,27,27,IGHV4-39,G,['G' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014
771,7TTM,H,28,28,IGHV4-39,S,['S' 'Y'],Y,Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014
772,5EA0,H,33,33,IGHV3-30,G,['A' 'G'],A,Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens
773,5EA0,H,50,50,IGHV3-30,V,['V' 'F'],F,Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens
774,5EA0,H,52,52,IGHV3-30,S,['S' 'R'],R,Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens
775,3KR3,H,50,50,IGHV3-23,V,['A' 'V'],A,Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens
776,3KR3,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens
777,3KR3,H,52A,53,IGHV3-23,S,['G' 'S'],G,Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens
778,3KR3,H,53,54,IGHV3-23,S,['S' 'G'],G,Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens
779,3KR3,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens
780,7F1G,D,58,218,IGHV3-74,T,['S' 'T'],S,"BACE2 xaperone complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxamide",beta-secretase 2,A,homo sapiens
781,7FJC,L,50,50,IGKV1-5,D,['D' 'K'],K,Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
782,6BQB,H,35,35,IGHV3-33,H,['H' 'Y'],Y,MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum
783,6BQB,H,52,52,IGHV3-33,W,['W' 'S'],S,MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum
784,6BQB,H,94,94,IGHV3-33,K,['R' 'K'],R,MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum
785,6MTO,H,33,33,IGHV1-69,T,['A' 'T'],A,Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
786,6MTO,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
787,6MTO,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
788,6MTT,H,33,33,IGHV1-69,T,['A' 'T'],A,Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1
789,6MTT,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1
790,6MTT,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1
791,6MTT,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1
792,6MTT,H,71,71,IGHV1-69,A,['A' 'T'],T,Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1
793,6MTQ,H,33,33,IGHV1-69,T,['A' 'T'],A,Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
794,6MTQ,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
795,6MTQ,H,73,73,IGHV1-69,K,['E' 'K'],E,Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1
796,5UCB,L,30,30,IGKV1-13,S,['I' 'S'],I,Structure of antigen-Fab complex with engineered switch residue region.,histone chaperone asf1,B,saccharomyces cerevisiae (strain atcc 204508 /s288c) 
797,5UCB,L,32,32,IGKV1-13,A,['S' 'A'],S,Structure of antigen-Fab complex with engineered switch residue region.,histone chaperone asf1,B,saccharomyces cerevisiae (strain atcc 204508 /s288c) 
798,7A3O,L,50,50,IGLV2-14,D,['E' 'D'],E,Crystal structure of dengue 1 virus envelope glycoprotein in complex with the scFv fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,dengue virus 1
799,6GG0,H,33,33,IGHV4-31,G,['G' 'S'],S,Cryo-EM structure of BK polyomavirus like particle in complex with single chain antibody ScFv41F17,capsid protein vp1 | capsid protein vp1,4 | 3,bk polyomavirus | bk polyomavirus
800,4XNY,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1
801,4XNY,H,61,61,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1
802,4XNY,H,69,69,IGHV1-2,M,['S' 'M'],S,Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1
803,7YUE,A,50,52,IGHV3-23,A,['A' 'V'],V,Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region.,spike protein s2,C,severe acute respiratory syndrome coronavirus2 
804,7YUE,A,52,54,IGHV3-23,S,['S' 'Y'],Y,Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region.,spike protein s2,C,severe acute respiratory syndrome coronavirus2 
805,5VAG,C,54,55,IGHV1-69,F,['F' 'L'],L,Crystal structure of H7-specific antibody m826 in complex with the HA1 domain of hemagglutinin from H7N9 influenza virus,hemagglutinin,A,influenza a virus
806,5VAG,C,56,57,IGHV1-69,T,['T' 'I'],I,Crystal structure of H7-specific antibody m826 in complex with the HA1 domain of hemagglutinin from H7N9 influenza virus,hemagglutinin,A,influenza a virus
807,7VKE,B,60,61,IGHV3-30,A,['A' 'T'],T,Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens
808,6UCE,H,50,50,IGHV1-2,W,['R' 'W'],R,N123-VRC34_pI3 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519,hiv fusion peptide,C,human immunodeficiency virus 1
809,8ERQ,H,54,56,IGHV2-5,D,['N' 'D'],N,SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
810,8ERQ,L,32,35,IGLV2-14,Y,['Y' 'L'],L,SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
811,8ERQ,L,50,53,IGLV2-14,E,['E' 'D'],D,SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
812,7T0Z,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens
813,7T0Z,H,52A,53,IGHV3-23,G,['G' 'S'],S,Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens
814,7T0Z,H,53,54,IGHV3-23,S,['S' 'G'],G,Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens
815,3GHE,L,29,29,IGLV2-14,G,['G' 'S'],S,Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN,envelope glycoprotein,P,
816,3GHE,L,32,32,IGLV2-14,Y,['Y' 'L'],L,Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN,envelope glycoprotein,P,
817,7PRZ,H,26,26,IGHV3-30,G,['G' 'A'],A,Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 
818,7PRZ,H,94,98,IGHV3-30,K,['R' 'K'],R,Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 
819,3IDG,A,32,32,IGKV1-13,A,['S' 'A'],S,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWD,gp41 mper peptide,C,
820,3IDG,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWD,gp41 mper peptide,C,
821,6WHK,B,50,51,IGLV1-51,D,['D' 'E'],E,Minimally mutated anti-influenza broadly neutralizing antibody,hemagglutinin ha1 chain,A,influenza a virus (a/beijing/262/1995(h1n1))
822,7WVG,C,52,82,IGHV3-30,S,['S' 'R'],R,Crystal structure of H18 complexed with SIA28,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus
823,7KPG,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Blocking Fab 25 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens
824,7KPG,H,53,53,IGHV3-23,S,['S' 'G'],G,Blocking Fab 25 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens
825,7D0B,H,54,56,IGHV2-5,D,['N' 'D'],N,S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
826,7BBG,H,54,55,IGHV1-69,F,['F' 'L'],L,CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens
827,7BBG,H,56,57,IGHV1-69,T,['T' 'I'],I,CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens
828,7BBG,L,50,50,IGKV1-5,D,['D' 'K'],K,CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens
829,7DX4,H,33,34,IGHV1-69,A,['A' 'T'],T,The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
830,7DX4,H,56,58,IGHV1-69,I,['T' 'I'],T,The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
831,7DX4,H,73,75,IGHV1-69,K,['E' 'K'],E,The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
832,7DX4,L,69,71,IGLV1-40,T,['T' 'A'],A,The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
833,7LXW,H,52,52,IGHV3-33,W,['W' 'S'],S,SARS-CoV-2 S/S2M11/S2X333 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
834,7LXW,L,50,49,IGLV3-21,D,['Y' 'D'],Y,SARS-CoV-2 S/S2M11/S2X333 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
835,3DVG,A,30,30,IGKV1-13,S,['I' 'S'],I,Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens
836,3DVG,A,32,32,IGKV1-13,A,['S' 'A'],S,Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens
837,4JB9,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
838,6YIO,L,50,50,IGKV1-5,K,['D' 'K'],D,CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens
839,1NL0,H,33,33,IGHV3-30,A,['A' 'G'],G,"Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12",factor ix,G,
840,1NL0,H,52,52,IGHV3-30,S,['S' 'R'],R,"Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12",factor ix,G,
841,7CE2,Z,33,33,IGHV4-59,Y,['Y' 'S'],S,The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani
842,7CE2,Z,50,50,IGHV4-59,Y,['Y' 'R'],R,The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani
843,7CE2,Z,53,53,IGHV4-59,Y,['Y' 'T'],T,The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani
844,7CE2,Z,58,58,IGHV4-59,N,['N' 'Y'],Y,The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani
845,5WB9,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of CD4 binding site antibody N60P23 in complex with HIV-1 clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
846,3D0L,A,32,32,IGKV1-13,A,['S' 'A'],S,Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671,hyb3k peptide construct,C,
847,3D0L,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671,hyb3k peptide construct,C,
848,6YIO,H,33,33,IGHV1-69,A,['A' 'T'],T,CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens
849,6YIO,H,54,55,IGHV1-69,F,['F' 'L'],L,CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens
850,6YIO,H,73,74,IGHV1-69,E,['E' 'K'],K,CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens
851,6WFY,H,31,31,IGHV3-49,D,['D' 'Y'],Y,Crystal structure of Fab224 in complex with NPNA4 peptide from circumsporozoite protein,npna4 peptide,P,plasmodium falciparum
852,6WFY,H,33,33,IGHV3-49,A,['A' 'P'],P,Crystal structure of Fab224 in complex with NPNA4 peptide from circumsporozoite protein,npna4 peptide,P,plasmodium falciparum
853,6WFX,H,31,31,IGHV3-33,S,['S' 'R'],R,Crystal structure of Fab395 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum
854,6WFX,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of Fab395 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum
855,7X8W,H,50,50,IGHV1-2,W,['R' 'W'],R,The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
856,5VZY,H,52A,52A,IGHV3-23,S,['G' 'S'],G,Crystal structure of crenezumab Fab in complex with Abeta,amyloid beta,A,homo sapiens
857,2B4C,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody,envelope glycoprotein | t-cell surface glycoprotein cd4,G | C,human immunodeficiency virus 1 | homo sapiens
858,2B4C,H,56,56,IGHV1-69,T,['T' 'I'],I,Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody,envelope glycoprotein | t-cell surface glycoprotein cd4,G | C,human immunodeficiency virus 1 | homo sapiens
859,8DCE,H,32,190,IGLV2-14,Y,['Y' 'L'],L,SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
860,7F7E,C,53,68,IGHV3-23,S,['S' 'G'],G,SARS-CoV-2 S protein RBD in complex with A5-10 Fab,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
861,3UJJ,L,50,50,IGLV3-10,E,['E' 'K'],K,Crystal structure of anti-HIV-1 V3 Fab 4025 in complex with Con A peptide,gp120,P,human immunodeficiency virus 1
862,6AL5,H,73,74,IGHV1-69,E,['E' 'K'],K,COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB,b-lymphocyte antigen cd19,A,homo sapiens
863,4YDI,H,50,50,IGHV1-2,W,['R' 'W'],R,"Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17",envelope glycoprotein gp160,G,human immunodeficiency virus 1
864,4YDI,H,61,61,IGHV1-2,H,['Q' 'H'],Q,"Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17",envelope glycoprotein gp160,G,human immunodeficiency virus 1
865,4YDK,H,55,55,IGHV3-23,G,['G' 'S'],S,Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160",G,human immunodeficiency virus 1
866,5Y9J,H,54,55,IGHV1-69,F,['F' 'L'],L,BAFF in complex with belimumab,tumor necrosis factor ligand superfamily member 13b,A,homo sapiens
867,5Y9J,H,56,57,IGHV1-69,T,['T' 'I'],I,BAFF in complex with belimumab,tumor necrosis factor ligand superfamily member 13b,A,homo sapiens
868,5IGX,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120,426c.tm1deltav1-3 gp120,G,human immunodeficiency virus 1
869,5IGX,H,61,61,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120,426c.tm1deltav1-3 gp120,G,human immunodeficiency virus 1
870,7SK9,F,52,55,IGHV3-23,S,['S' 'Y'],Y,"Cryo-EM structure of human ACKR3 in complex with a small molecule partial agonist CCX662, and an intracellular Fab",atypical chemokine receptor 3,A,homo sapiens
871,7SK9,F,53,57,IGHV3-23,S,['S' 'G'],G,"Cryo-EM structure of human ACKR3 in complex with a small molecule partial agonist CCX662, and an intracellular Fab",atypical chemokine receptor 3,A,homo sapiens
872,7SK6,F,52,55,IGHV3-23,S,['S' 'Y'],Y,Cryo-EM structure of human ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ and an intracellular Fab,atypical chemokine receptor 3,A,homo sapiens
873,7SK6,F,53,57,IGHV3-23,S,['S' 'G'],G,Cryo-EM structure of human ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ and an intracellular Fab,atypical chemokine receptor 3,A,homo sapiens
874,5KJR,H,33,33,IGHV4-31,G,['G' 'S'],S,Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
875,5KJR,L,29,29,IGLV2-14,G,['G' 'S'],S,Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
876,5KJR,L,32,32,IGLV2-14,Y,['Y' 'L'],L,Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1
877,6UOE,H,52,52,IGHV3-30,S,['S' 'R'],R,3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide,envelope glycoprotein b,P,human betaherpesvirus 5
878,6UOE,H,94,94,IGHV3-30,R,['R' 'K'],K,3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide,envelope glycoprotein b,P,human betaherpesvirus 5
879,3MOD,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced IgG) with 11 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,homo sapiens
880,3MOA,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) with 17 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,
881,3MOB,H,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) with 11 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,
882,4LSU,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1
883,4LSV,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120,envelope glycoprotein gp120,G,human immunodeficiency virus 1
884,4LSQ,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1,envelope glycoprotein gp120 with loop d and v5 from strain3415_v1_c1 ,G,human immunodeficiency virus 1
885,4LSP,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1
886,4LSR,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11,envelope glycoprotein gp120 with loop d and v5 from strainker_2018_11 ,G,human immunodeficiency virus 1
887,7DAA,L,50,51,IGKV1-5,D,['D' 'K'],K,Crystal structure of basigin complexed with anti-basigin Fab fragment,isoform 2 of basigin,A,homo sapiens
888,7CDJ,H,54,55,IGHV3-11,G,['G' 'S'],S,Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
889,7CDJ,H,56,57,IGHV3-11,T,['T' 'Y'],Y,Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
890,7CDJ,H,58,59,IGHV3-11,Y,['Y' 'N'],N,Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
891,7CDI,H,54,54,IGHV3-66,G,['G' 'C'],C,Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
892,7MZL,H,26,26,IGHV4-34,G,['G' 'F'],F,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
893,7MZL,H,28,28,IGHV4-34,T,['S' 'T' 'G'],S,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
894,7MZL,H,28,28,IGHV4-34,T,['S' 'T' 'G'],G,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
895,7MZL,H,30,30,IGHV4-34,S,['S' 'Y'],Y,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
896,7MZL,H,31,31,IGHV4-34,G,['G' 'W'],W,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
897,7MZL,H,32,32,IGHV4-34,Y,['Y' 'S'],S,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
898,7MZL,H,50,50,IGHV4-34,E,['E' 'Y'],Y,SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
899,7MZM,H,54,55,IGHV3-11,S,['G' 'S'],G,SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
900,7MZM,H,57,58,IGHV3-11,T,['I' 'T'],I,SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
901,7MZM,H,58,59,IGHV3-11,N,['Y' 'N'],Y,SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
902,4NZR,H,1,1,IGHV4-39,Q,['Q' 'R'],R,Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-HIV antibody PGT135 Fab,protein m td,M,mycoplasma genitalium
903,4NZR,H,26,26,IGHV4-39,G,['G' 'S'],S,Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-HIV antibody PGT135 Fab,protein m td,M,mycoplasma genitalium
904,4NZT,L,43,43,IGLV1-44,A,['A' 'G'],G,Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-infleunza hemagglutinin antibody CR9114 Fab,protein m td,M,mycoplasma genitalium
905,4NZT,L,59,59,IGLV1-44,P,['P' 'L'],L,Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-infleunza hemagglutinin antibody CR9114 Fab,protein m td,M,mycoplasma genitalium
906,3DRO,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN grown in ammonium sulfate,elleldkwaslwn gp41 peptide,P,
907,3DRQ,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671 soaked in PEG/2-propanol solution,gp41 peptide epitope,C,
908,3DRT,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 scrambledFP-MPER scrHyb3K construct GIGAFGLLGFLAAGSKK-Ahx-K656NEQELLELDKWASLWN671,scrhyb3k construct,C,
909,7WE8,H,54,56,IGHV2-5,D,['N' 'D'],N,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
910,7WE8,L,29,32,IGLV2-14,G,['G' 'S'],S,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
911,7WE8,L,32,35,IGLV2-14,Y,['Y' 'L'],L,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
912,7WE8,L,50,53,IGLV2-14,E,['E' 'D'],D,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
913,7WE8,L,60,63,IGLV2-14,N,['N' 'D'],D,SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
914,6XY2,H,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens
915,6XY2,H,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens
916,6XY2,H,58,58,IGHV4-59,N,['N' 'Y'],Y,Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens
917,7WEE,H,54,56,IGHV2-5,D,['N' 'D'],N,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 
918,7WEE,L,32,35,IGLV2-14,Y,['Y' 'L'],L,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 
919,5IES,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.16 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens
920,5IES,H,61,61,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.16 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens
921,4EDW,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],S,Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens
922,4EDW,H,32,32,IGHV4-4,Y,['S' 'W' 'Y'],W,Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens
923,7KTX,I,25,27,IGHV4-34,Y,['Y' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
924,7KTX,I,26,28,IGHV4-34,G,['G' 'F'],F,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
925,7KTX,I,27,29,IGHV4-34,G,['G' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
926,7KTX,I,28,30,IGHV4-34,S,['S' 'T' 'G'],T,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
927,7KTX,I,28,30,IGHV4-34,S,['S' 'T' 'G'],G,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
928,7KTX,I,29,31,IGHV4-34,F,['F' 'V' 'Y'],V,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
929,7KTX,I,29,31,IGHV4-34,F,['F' 'V' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
930,7KTX,I,30,32,IGHV4-34,S,['S' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
931,7KTX,I,31,33,IGHV4-34,G,['G' 'W'],W,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
932,7KTX,I,32,34,IGHV4-34,Y,['Y' 'S'],S,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
933,7KTX,I,52,54,IGHV4-34,N,['N' 'Y' 'I'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
934,7KTX,I,52,54,IGHV4-34,N,['N' 'Y' 'I'],I,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
935,7KTX,I,53,55,IGHV4-34,H,['H' 'Y'],Y,Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743
936,7MZF,H,54,54,IGHV3-66,G,['G' 'C'],C,SARS-CoV-2 receptor binding domain bound to Fab PDI 37,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
937,7MZG,H,54,54,IGHV3-66,G,['G' 'C'],C,SARS-CoV-2 receptor binding domain bound to Fab PDI 42,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
938,7MZI,H,50,50,IGHV3-23,A,['A' 'V'],V,SARS-CoV-2 receptor binding domain bound to Fab WCSL 129,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
939,7MZI,H,52,52,IGHV3-23,S,['S' 'Y'],Y,SARS-CoV-2 receptor binding domain bound to Fab WCSL 129,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
940,7SIX,H,73,75,IGHV4-31,T,['T' 'K' 'P'],K,Antibody N3-1 bound to RBDs in the up and down conformations,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
941,7SIX,H,73,75,IGHV4-31,T,['T' 'K' 'P'],P,Antibody N3-1 bound to RBDs in the up and down conformations,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
942,3LEV,H,54,54,IGHV2-5,D,['N' 'D'],N,HIV-1 antibody 2F5 in complex with epitope scaffold ES2,rna polymerase sigma factor,A,thermus aquaticus
943,6PDU,L,27D,30A,IGKV2-30,H,['Y' 'H'],Y,Vaccine-elicited NHP FP-targeting antibody 13N024-a.01 in complex with HIV fusion peptide (residue 512-519),hiv-1 fusion peptide residue 512-519,C,human immunodeficiency virus 1
944,4JDT,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1
945,4JDT,H,61,61,IGHV1-2,Q,['Q' 'H'],H,Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1
946,4JDT,H,69,69,IGHV1-2,M,['S' 'M'],S,Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1
947,1RZK,H,54,54,IGHV1-69,L,['F' 'L'],F,HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1
948,1RZJ,H,54,54,IGHV1-69,L,['F' 'L'],F,HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1
949,2XRA,H,33,33,IGHV1-69,A,['A' 'T'],T,crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct
950,2XRA,H,54,54,IGHV1-69,F,['F' 'L'],L,crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct
951,2XRA,H,56,56,IGHV1-69,I,['T' 'I'],T,crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct
952,4FQJ,L,50,50,IGLV1-47,R,['R' 'S'],S,Influenza B/Florida/4/2006 hemagglutinin Fab CR8071 complex,hemagglutinin,A,influenza b virus
953,7CHZ,H,55,56,IGHV3-23,G,['G' 'S'],S,Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26A,interleukin-1 beta,I,homo sapiens
954,6Q0L,H,26,26,IGHV4-4,G,['G' 'S'],S,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
955,6Q0L,H,27,27,IGHV4-4,G,['G' 'I'],I,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
956,6Q0L,H,31,31,IGHV4-4,S,['S' 'N'],N,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
957,6Q0L,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
958,6Q0L,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
959,6Q0L,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],W,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
960,6Q0L,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],Y,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
961,6Q0L,H,34,34,IGHV4-4,W,['W' 'S'],S,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
962,6Q0L,H,53,54,IGHV4-4,H,['H' 'T'],T,Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
963,4N0Y,H,51,51,IGHV1-3,I,['I' 'S'],S,Structure of the Hepatitis C Envelope Glycoprotein E1 antigenic region 314-324 bound to the cross-neutralizing antibody IGH526,hcv e1 peptide,A,hepatitis c virus
964,6W7S,H,26,28,IGHV3-30,G,['G' 'A'],A,Ketoreductase from module 1 of the 6-deoxyerythronolide B synthase (KR1) in complex with antibody fragment (Fab) 2G10,eryai,A,saccharopolyspora erythraea
965,5TFW,H,50,50,IGHV3-15,R,['R' 'C'],C,"Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold",10e8 epitope scaffold t117v2,O,synthetic construct
966,1U95,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDHWAS,gp41 peptide,C,human immunodeficiency virus 1
967,1U91,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog ENDKW-[Dap]-S (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1
968,1U93,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog EQDKW-[Dap]-S (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1
969,1U92,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog E-[Dap]-DKWQS (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1
970,4G6J,H,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab,interleukin-1 beta,A,homo sapiens
971,4G6J,H,94,98,IGHV3-33,R,['R' 'K'],K,Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab,interleukin-1 beta,A,homo sapiens
972,4G6M,H,54,56,IGHV2-5,D,['N' 'D'],N,Crystal strucure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab,interleukin-1 beta,A,homo sapiens
973,7SOD,H,26,26,IGHV3-30,G,['G' 'A'],A,SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
974,7SOD,H,33,33,IGHV3-30,G,['A' 'G'],A,SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
975,7SOD,H,52,52,IGHV3-30,R,['S' 'R'],S,SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
976,7SO5,H,30,30,IGHV4-34,S,['S' 'Y'],Y,Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291
977,7SO5,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],Y,Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291
978,7SO5,H,52,52,IGHV4-34,N,['N' 'Y' 'I'],I,Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291
979,7SO5,H,53,53,IGHV4-34,Y,['H' 'Y'],H,Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291
980,4RQS,D,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab,hiv-1 yu2 gp120 core chimeric protein,G,homo sapiens
981,4DGY,H,52,52,IGHV3-33,W,['W' 'S'],S,"Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the broadly neutralizing antibody HCV1, C2 form",e2 peptide,A,hepatitis c virus
982,4DGV,H,52,52,IGHV3-33,W,['W' 'S'],S,"Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the broadly neutralizing antibody HCV1, P2(1) form",e2 peptide,A,hepatitis c virus
983,6R2S,A,50,69,IGKV1-5,K,['D' 'K'],D,The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i)
984,6R2S,B,26,45,IGHV4-39,G,['G' 'S'],S,The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i)
985,6R2S,B,27,46,IGHV4-39,G,['G' 'Y'],Y,The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i)
986,4RWY,H,30,30,IGHV1-46,N,['T' 'N'],T,Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC131 in complex with HIV-1 clade B YU2 gp120,hiv-1 yu2 gp120,A,human immunodeficiency virus 1
987,2YSS,B,31,31,IGHV4-59,S,['S' 'Y'],Y,Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus
988,2YSS,B,33,33,IGHV4-59,Y,['Y' 'S'],S,Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus
989,2YSS,B,50,50,IGHV4-59,Y,['Y' 'R'],R,Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus
990,2YSS,B,53,53,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus
991,2YSS,B,58,58,IGHV4-59,Y,['N' 'Y'],N,Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus
992,7DK0,A,50,50,IGHV1-69,R,['G' 'R'],G,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
993,7DK0,A,54,55,IGHV1-69,F,['F' 'L'],L,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
994,6MEH,H,33,33,IGHV1-69,A,['A' 'T'],T,Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c
995,6MEI,H,73,73,IGHV1-69,E,['E' 'K'],K,Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c
996,7XXL,C,32,34,IGLV2-14,Y,['Y' 'L'],L,RBD in complex with Fab14,spike protein s1,B,severe acute respiratory syndrome coronavirus2 
997,7N0A,B,29,29,IGHV3-15,F,['F' 'C'],C,Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens
998,7N0A,B,52,52,IGHV3-15,K,['K' 'E'],E,Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens
999,7N0A,B,53,56,IGHV3-15,D,['D' 'N'],N,Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens
1000,2B0S,L,50,50,IGLV1-47,R,['R' 'S'],S,Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide,mn peptide of exterior membrane glycoprotein gp120,P,
1001,7SSC,H,52,52,IGHV3-30,S,['S' 'R'],R,TRL345 lineage ancestor I8 Fab bound to an HCMV gB-derived peptide,envelope glycoprotein b peptide,P,human betaherpesvirus 5
1002,7SSC,H,94,94,IGHV3-30,R,['R' 'K'],K,TRL345 lineage ancestor I8 Fab bound to an HCMV gB-derived peptide,envelope glycoprotein b peptide,P,human betaherpesvirus 5
1003,5XWD,D,50,50,IGLV3-21,Y,['Y' 'D'],D,Crystal structure of the complex of 059-152-Fv and EGFR-ECD,epidermal growth factor receptor,A,homo sapiens
1004,5XWD,H,30,30,IGHV4-39,S,['S' 'G'],G,Crystal structure of the complex of 059-152-Fv and EGFR-ECD,epidermal growth factor receptor,A,homo sapiens
1005,2FX7,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,
1006,2FX7,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,
1007,2FX7,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,
1008,2FX7,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,
1009,2NXY,D,54,3055,IGHV1-69,L,['F' 'L'],F,HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b,envelope glycoprotein gp120,A,human immunodeficiency virus 1
1010,7KCR,H,50,50,IGHV3-30,F,['V' 'F'],V,Cryo-EM structure of Zika virus in complex with E protein cross-linking human monoclonal antibody ADI30056,envelope protein e | envelope protein e | envelope protein e,C | A | E,zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013 
1011,7KCR,H,52,52,IGHV3-30,R,['S' 'R'],S,Cryo-EM structure of Zika virus in complex with E protein cross-linking human monoclonal antibody ADI30056,envelope protein e | envelope protein e | envelope protein e,C | A | E,zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013 
1012,6TOU,A,33,33,IGHV4-31,S,['G' 'S'],G,Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20,"glycoprotein,glycoprotein",G,rabies lyssavirus
1013,6TOU,A,50,50,IGHV4-31,Y,['Y' 'C'],C,Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20,"glycoprotein,glycoprotein",G,rabies lyssavirus
1014,4XBE,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1
1015,4XBE,H,50,50,IGHV1-69,G,['G' 'R'],R,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1
1016,4XBE,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1
1017,4XBE,H,56,56,IGHV1-69,I,['T' 'I'],T,Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1
1018,4JHW,H,54,54,IGHV1-69,L,['F' 'L'],F,Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25,fusion glycoprotein f0,F,human respiratory syncytial virus
1019,7WON,H,94,98,IGHV3-30,R,['R' 'K'],K,Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 
1020,7WOG,A,52,52,IGHV3-23,S,['S' 'Y'],Y,SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1021,7WOG,A,53,54,IGHV3-23,S,['S' 'G'],G,SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1022,7WOG,A,55,56,IGHV3-23,G,['G' 'S'],S,SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1023,7WOC,A,54,55,IGHV1-69,L,['F' 'L'],F,"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1024,7WOC,A,56,57,IGHV1-69,I,['T' 'I'],T,"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1025,7WOC,A,73,74,IGHV1-69,K,['E' 'K'],E,"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1026,7DM2,L,50,54,IGLV1-47,R,['R' 'S'],S,crystal structure of the M. tuberculosis phosphate ABC transport receptor PstS-1 in complex with Fab p4-170,phosphate-binding protein psts 1,A,mycobacterium tuberculosis h37rv
1027,6VC9,H,31,31,IGHV4-4,N,['S' 'N'],S,TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens
1028,6VC9,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],N,TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens
1029,6VC9,H,33,33,IGHV4-4,Y,['N' 'W' 'Y'],W,TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens
1030,6VC9,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],E,TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens
1031,6VC9,H,50,50,IGHV4-4,R,['E' 'R' 'Y'],Y,TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens
1032,4Z0X,B,50,75,IGHV1-69,G,['G' 'R'],R,Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus
1033,4Z0X,B,54,80,IGHV1-69,F,['F' 'L'],L,Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus
1034,4Z0X,B,56,82,IGHV1-69,T,['T' 'I'],I,Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus
1035,7RP3,H,26,26,IGHV4-4,G,['G' 'S'],S,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1036,7RP3,H,27,27,IGHV4-4,G,['G' 'I'],I,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1037,7RP3,H,31,31,IGHV4-4,S,['S' 'N'],N,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1038,7RP3,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1039,7RP3,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1040,7RP3,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],W,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1041,7RP3,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],Y,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1042,7RP3,H,53,53,IGHV4-4,H,['H' 'T'],T,Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens
1043,2VXQ,H,33,32,IGHV4-31,G,['G' 'S'],S,Crystal structure of the major grass pollen allergen Phl p 2 in  complex with its specific IgE-Fab,pollen allergen phl p 2,A,phleum pratense
1044,6W16,H,26,27,IGHV3-30,G,['G' 'A'],A,Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab,"fusion glycoprotein f0,envelope glycoprotein fusion",F,"human metapneumovirus, human immunodeficiencyvirus 1 "
1045,6W16,H,33,38,IGHV3-30,G,['A' 'G'],A,Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab,"fusion glycoprotein f0,envelope glycoprotein fusion",F,"human metapneumovirus, human immunodeficiencyvirus 1 "
1046,7MRZ,X,28,28,IGHV4-39,S,['S' 'Y'],Y,Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment,"activin receptor type-2b,activin receptor type-1b",C,homo sapiens
1047,7MRZ,X,30,30,IGHV4-39,S,['S' 'G'],G,Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment,"activin receptor type-2b,activin receptor type-1b",C,homo sapiens
1048,8DFH,H,52,52,IGHV3-30,R,['S' 'R'],S,Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7
1049,8DFH,L,50,51,IGLV1-47,R,['R' 'S'],S,Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7
1050,8DFI,H,50,50,IGHV3-30,F,['V' 'F'],V,Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7
1051,8DFI,H,52,52,IGHV3-30,R,['S' 'R'],S,Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7
1052,8DFI,L,50,51,IGLV1-47,R,['R' 'S'],S,Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7
1053,8D36,H,50,50,IGHV1-2,R,['R' 'W'],W,Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62,spike protein s2 fusion peptide,F,severe acute respiratory syndrome coronavirus2 
1054,6IVZ,H,26,27,IGHV4-59,G,['G' 'S'],S,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1055,6IVZ,H,27,28,IGHV4-59,G,['G' 'I'],I,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1056,6IVZ,H,30,31,IGHV4-59,Y,['S' 'Y'],S,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1057,6IVZ,H,32,33,IGHV4-59,H,['Y' 'W' 'H'],Y,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1058,6IVZ,H,32,33,IGHV4-59,H,['Y' 'W' 'H'],W,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1059,6IVZ,H,53,54,IGHV4-59,Y,['Y' 'T'],T,Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus
1060,3LZF,H,33,33,IGHV2-70,G,['G' 'E'],E,Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin,"hemagglutinin, ha1 subunit",A,influenza a virus
1061,3LZF,H,50,50,IGHV2-70,L,['L' 'R'],R,Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin,"hemagglutinin, ha1 subunit",A,influenza a virus
1062,6XQW,H,50,50,IGHV4-34,E,['E' 'Y'],Y,Crystal Structure of MaliM03 Fab in complex with Pfmsp1-19,pfmsp1-19,E,plasmodium falciparum
1063,6XQW,L,50,50,IGLV1-47,R,['R' 'S'],S,Crystal Structure of MaliM03 Fab in complex with Pfmsp1-19,pfmsp1-19,E,plasmodium falciparum
1064,3MAC,H,33,33,IGHV1-69,A,['A' 'T'],T,crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1
1065,3MAC,H,54,54,IGHV1-69,F,['F' 'L'],L,crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1
1066,7A3U,L,50,50,IGLV2-14,D,['E' 'D'],E,Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus
1067,7A3U,L,51,51,IGLV2-14,V,['V' 'G'],G,Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus
1068,7A3N,L,50,50,IGLV2-14,D,['E' 'D'],E,Crystal structure of Zika virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,zika virus
1069,4I3R,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus
1070,4I3S,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P21,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus
1071,4ERS,L,10,10,IGKV1-17,S,['S' 'A'],A,A Molecular Basis for Negative Regulation of the Glucagon Receptor,glucagon receptor,A,homo sapiens
1072,4ERS,L,11,11,IGKV1-17,L,['L' 'M'],M,A Molecular Basis for Negative Regulation of the Glucagon Receptor,glucagon receptor,A,homo sapiens
1073,7N4I,H,74,75,IGHV5-51,S,['S' 'P'],P,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.,spike protein s1,C,severe acute respiratory syndrome coronavirus2 
1074,7N4N,D,58,218,IGHV3-74,T,['S' 'T'],S,BACE-2 in complex with ligand 36,beta-secretase 2,A,homo sapiens
1075,7N4L,H,50,50,IGHV3-30,V,['V' 'F'],F,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
1076,7N4L,H,52,52,IGHV3-30,S,['S' 'R'],R,Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.,spike protein s1,A,severe acute respiratory syndrome coronavirus2 
1077,4HKX,A,50,50,IGHV1-2,W,['R' 'W'],R,Influenza hemagglutinin in complex with CH67 Fab,hemagglutinin ha1,E,influenza a virus
1078,1G9M,H,54,55,IGHV1-69,L,['F' 'L'],F,HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1
1079,3MA9,H,33,33,IGHV1-69,A,['A' 'T'],T,Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1
1080,3MA9,H,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1
1081,3MA9,H,56,56,IGHV1-69,T,['T' 'I'],I,Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1
1082,3MA9,H,73,73,IGHV1-69,E,['E' 'K'],K,Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1
1083,5SY8,H,50,50,IGHV3-15,R,['R' 'C'],C,Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold,10e8 epitope scaffold t117v2,O,synthetic construct
1084,7YE5,H,33,33,IGHV1-69,A,['A' 'T'],T,SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
1085,7YE5,H,54,55,IGHV1-69,L,['F' 'L'],F,SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
1086,7YE5,H,56,57,IGHV1-69,I,['T' 'I'],T,SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
1087,7YE5,H,73,74,IGHV1-69,K,['E' 'K'],E,SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
1088,7YE5,L,69,71,IGLV1-40,T,['T' 'A'],A,SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 
1089,6AXK,A,35,35,IGHV3-33,H,['H' 'Y'],Y,Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum
1090,6AXK,A,52,52,IGHV3-33,W,['W' 'S'],S,Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum
1091,6AXK,A,94,94,IGHV3-33,R,['R' 'K'],K,Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum
1092,7SWP,H,26,26,IGHV3-30,G,['G' 'A'],A,G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
1093,7SWP,H,94,98,IGHV3-30,R,['R' 'K'],K,G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
1094,6Q0O,Z,31,31,IGHV4-4,S,['S' 'N'],N,human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus
1095,6Q0O,Z,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus
1096,6Q0O,Z,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus
1097,6Q0O,Z,34,34,IGHV4-4,W,['W' 'S'],S,human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus
1098,6Q0O,Z,53,54,IGHV4-4,H,['H' 'T'],T,human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus
1099,7SWO,H,54,54,IGHV3-66,G,['G' 'C'],C,C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 
1100,6Q0I,H,31,31,IGHV4-4,S,['S' 'N'],N,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1101,6Q0I,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1102,6Q0I,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1103,6Q0I,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],W,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1104,6Q0I,H,33,33,IGHV4-4,N,['N' 'W' 'Y'],Y,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1105,6Q0I,H,34,34,IGHV4-4,W,['W' 'S'],S,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1106,6Q0I,H,53,54,IGHV4-4,H,['H' 'T'],T,Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1107,6Q0H,H,31,31,IGHV4-4,S,['S' 'N'],N,Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1108,6Q0H,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1109,6Q0H,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1110,6Q0H,H,34,34,IGHV4-4,W,['W' 'S'],S,Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1111,6Q0H,H,53,54,IGHV4-4,H,['H' 'T'],T,Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1112,6Q0E,H,31,31,IGHV4-4,S,['S' 'N'],N,Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1113,6Q0E,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],W,Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1114,6Q0E,H,32,32,IGHV4-4,S,['S' 'W' 'Y'],Y,Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1115,6Q0E,H,53,54,IGHV4-4,H,['H' 'T'],T,Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1))
1116,7CWO,H,33,33,IGHV3-30,A,['A' 'G'],G,SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1117,7CWO,H,50,50,IGHV3-30,V,['V' 'F'],F,SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1118,7CWO,H,52,52,IGHV3-30,S,['S' 'R'],R,SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1119,7CWO,H,94,98,IGHV3-30,R,['R' 'K'],K,SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1120,3R1G,H,52,52,IGHV3-23,S,['S' 'Y'],Y,Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody,beta-secretase 1,B,homo sapiens
1121,8E7M,H,52,52,IGHV3-23,S,['S' 'Y'],Y,"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens
1122,8E7M,H,52A,53,IGHV3-23,G,['G' 'S'],S,"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens
1123,8E7M,H,53,54,IGHV3-23,S,['S' 'G'],G,"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens
1124,8E7M,L,30,30,IGKV1-17,S,['R' 'S'],R,"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens
1125,8E7M,L,32,32,IGKV1-17,Y,['D' 'Y'],D,"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens
1126,7SOA,H,26,26,IGHV3-30,G,['G' 'A'],A,SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1127,7SOA,H,52,52,IGHV3-30,R,['S' 'R'],S,SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1128,3D0V,B,54,54,IGHV2-5,D,['N' 'D'],N,Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LLELDKWASLW,gp41 peptide lleldkwaslw,C,
1129,7LJR,S,50,69,IGHV1-69,R,['G' 'R'],G,SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1130,7LJR,S,54,74,IGHV1-69,F,['F' 'L'],L,SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1131,7LJR,S,56,76,IGHV1-69,I,['T' 'I'],T,SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 
1132,6YXK,A,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of ACPA 3F3 in complex with cit-vimentin 59-74,citrullinated vimentin (59-74),C,homo sapiens
1133,5T29,H,50,50,IGHV3-15,R,['R' 'C'],C,"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct
1134,5T29,H,58,58,IGHV3-15,D,['D' 'N'],N,"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct
1135,4XMP,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1
1136,7NCS,H,50,50,IGHV3-21,Y,['S' 'Y'],S,"Lateral-open conformation of the lid-locked BAM complex (BamA E435C S665C, BamBDCE) bound by a bactericidal Fab fragment",outer membrane protein assembly factor bama,A,escherichia coli k-12
1137,3NPS,B,54,54,IGHV1-69,F,['F' 'L'],L,Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4,suppressor of tumorigenicity 14 protein,A,homo sapiens
1138,5IQ7,H,50,50,IGHV3-15,R,['R' 'C'],C,Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.,gp41 mper peptide,P,human immunodeficiency virus 1
1139,5OCK,L,50,51,IGLV1-51,D,['D' 'E'],E,Crystal structure of ACPA E4 in complex with CEP1,cep1 peptide (from enolase),A,homo sapiens
1140,7WTG,H,33,33,IGHV1-69,A,['A' 'T'],T,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1141,7WTG,H,50,50,IGHV1-69,G,['G' 'R'],R,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1142,7WTG,H,54,55,IGHV1-69,F,['F' 'L'],L,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1143,7WTG,H,56,57,IGHV1-69,T,['T' 'I'],I,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1144,7WTG,L,30,30,IGKV1-17,R,['R' 'S'],S,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1145,7WTG,L,32,32,IGKV1-17,D,['D' 'Y'],Y,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1146,7WTH,H,54,56,IGHV2-5,D,['N' 'D'],N,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1147,7WTH,L,32,34,IGLV2-14,Y,['Y' 'L'],L,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1148,7WTH,L,50,52,IGLV2-14,E,['E' 'D'],D,SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 
1149,6H2Y,H,54,55,IGHV1-69,F,['F' 'L'],L,human Fab 1E6 bound to fHbp variant 3 from Neisseria meningitidis serogroup B,lipoprotein gna1870,D,neisseria meningitidis
1150,6H2Y,L,50,49,IGLV3-21,Y,['Y' 'D'],D,human Fab 1E6 bound to fHbp variant 3 from Neisseria meningitidis serogroup B,lipoprotein gna1870,D,neisseria meningitidis
1151,3SO3,C,50,50,IGHV3-23,A,['A' 'V'],V,Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens
1152,3SO3,C,52,52,IGHV3-23,S,['S' 'Y'],Y,Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens
1153,3SO3,C,52A,52A,IGHV3-23,G,['G' 'S'],S,Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens
1154,3SO3,C,53,53,IGHV3-23,S,['S' 'G'],G,Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens
1155,3SO3,C,55,55,IGHV3-23,G,['G' 'S'],S,Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens
1156,3SE8,H,50,50,IGHV1-2,W,['R' 'W'],R,Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1
